|
|
Drugs for Gastrointestinal Lymphoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show top 50)
(show all 503)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | Vinblastine | approved | Phase 4, Phase 3, Phase 2 | 420 | 865-21-4 | 13342, 241903 | (2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE (2xi,3beta,4'beta,19xi)-vincaleukoblastine (3aR-(3aalpha,4beta,5beta,5abeta,9(3R*,5S*,7R*,9S*),10bR*,13aalpha))-methyl 4-(acetyloxy)-3a-ethyl-9-(5-ethyl-1,4,5,6,7,8,9,10-octahydro-5-hydroxy-9-(methoxycarbonyl)-2H-3,7-methanoazacycloundecino(5,4-b)indol-9-yl)-3a,4,5,5a,6,11,12,13a-octahydro-5-hydroxy-8-methoxy-6-methyl-1H-indolizino(8,1-cd)carbazole-5-carboxylate 143-67-9 1z2b 29060-LE 865-21-4 AC-20335 AC1L21JC AC1L68D2 AC1MXZJ2 BIDD:PXR0201 BRD-K01188359-065-02-5 BSPBio_001228 BSPBio_003594 Bio-0111 C07201 C46H58N4O9 CCRIS 9002 CHEBI:171516 CHEBI:27375 CHEMBL159 CHEMBL607706 CID13342 CID241903 CID3823887 CID6710780 D08675 DB00570 EINECS 212-734-0 HMS2090K05 HSDB 3263 KBio3_003033 LS-1859 LS-187263 MolPort-002-518-262 | MolPort-005-910-359 NCGC00022585-04 NCGC00181127-01 NCI-C04842 NCI60_004200 NChemBio.2007.10-comp22 NDC 0002-1452-01 NSC 47842 Neuro_000020 Nincaluicolflastine Rozevin SPBio_000680 STOCK1N-38480 Spectrum2_000890 Spectrum3_001994 UNII-5V9KLZ54CY VLB VR-8 Velban Velbe Vinblastin Vinblastina Vinblastina (TN) Vinblastina [DCIT] Vinblastina [Dcit] Vinblastine Vinblastine (INN) Vinblastine Sulfate Vinblastine [INN:BAN] Vinblastinum Vinblastinum [INN-Latin] Vincaleucoblastin Vincaleucoblastine Vincaleukoblastine Vincoblastine nchembio873-comp22 vinblastine | |
| | 2 | | Cladribine | approved, investigational | Phase 4, Phase 1 | 73 | 4291-63-8 | 20279 | (2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol (2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol 2 Chlorodeoxyadenosine 2'-Deoxy-2-chloroadenosine 2-CdA 2-Chloro-2'-deoxy-beta-adenosine 2-Chloro-2'-deoxyadenosine 2-Chloro-6-amino-9-(2-deoxy-beta-D-erythropentofuranosyl)purine 2-Chlorodeoxyadenosine 2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine 2-chloro-6-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine 2-chloro-Deoxyadenosine 2-chloro-deoxyadenosine 24757-90-2 2CdA 2ClAdo 4291-63-8 AC-7591 AC1L2FXP Adenosine, 2-chloro-2'-deoxy BRN 0624220 C10H12ClN5O3.C3H8 CHEBI:567361 CHEMBL1619 CID20279 CL9 CPD000058553 Chlorodeoxyadenosine Cladarabine Cladaribine Cladribina Cladribine Cladribine (JAN/USAN/INN) Cladribine [USAN:INN:BAN] Cladribinum | CldAdo D01370 D017338 DB00242 FT-0080707 HMS2052K13 HSDB 7564 LS-15109 Leustat Leustatin Leustatin (TN) Leustatin, 2-chlorodeoxyadenosine, Cladribine Litak MLS000028377 MLS000028484 MLS000759397 MLS001077345 MolPort-002-054-532 MolPort-005-935-074 Movectro Mylinax NCGC00022567-05 NCGC00164384-01 NSC 105014 NSC 105014-F NSC-105014 RWJ 26251 RWJ-26251 RWJ-26251-000 S1199_Selleck SAM001246526 SMR000058553 UNII-47M74X9YT5 ZINC03798064 cladribina cladribine cladribinum |
| | 3 | | Cyclophosphamide | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 2935 | 50-18-0, 6055-19-2 | 2907 | (+-)-Cyclophosphamide (-)-Cyclophosphamide (RS)-Cyclophosphamide 1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine 1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin 2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide 4-Hydroxy-cyclophosphan-mamophosphatide 50-18-0 60007-95-6 6055-19-2 (monohydrate) 75526-90-8 AC1L1EQQ AI3-26198 ASTA ASTA B518 Anhydrous cyclophosphamide Asta B 518 B 518 B-518 BRN 0011744 BSPBio_002099 Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester C 0768 C07888 C7H15Cl2N2O2P CB 4564 CB-4564 CCRIS 188 CHEBI:4027 CHEMBL32520 CHEMBL88 CID2907 CP CPA CTX CY Ciclofosfamida Ciclofosfamida [INN-Spanish] Ciclofosfamide Ciclophosphamide Ciclophosphamide [INN] Clafen Claphene Cycloblastin Cyclophosphamid Cyclophosphamide Cyclophosphamide (INN) Cyclophosphamide (TN) Cyclophosphamide (anhydrous form) Cyclophosphamide (anhydrous) Cyclophosphamide Monohydrate Cyclophosphamide Sterile Cyclophosphamide anhydrous Cyclophosphamide, (+-)-Isomer Cyclophosphamides Cyclophosphamidum Cyclophosphamidum [INN-Latin] Cyclophosphan Cyclophosphane Cyclophosphanum Cyclophosphoramide Cyclostin Cyklofosfamid Cyklofosfamid [Czech] Cytophosphan Cytophosphane Cytoxan Cytoxan (TN) Cytoxan Lyoph D,L-Cyclophosphamide D07760 | DB00531 DivK1c_000246 EINECS 200-015-4 EU-0100238 Endoxan Endoxan R Endoxan-Asta Endoxana Endoxanal Endoxane Enduxan Genoxal HMS2090A12 HSDB 3047 Hexadrin IDI1_000246 KBio1_000246 KBio2_001338 KBio2_003906 KBio2_006474 KBio3_001319 KBioGR_000888 KBioSS_001338 LS-1302 LS-99787 Ledoxina Lopac-C-0768 Lopac0_000238 Lyophilized Cytoxan Mitoxan MolPort-001-783-420 N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide NCGC00015209-01 NCGC00015209-03 NCGC00015209-06 NCGC00091741-02 NCGC00091741-03 NCI-C04900 NCI60_002097 NINDS_000246 NSC 26271 NSC-26271 NSC26271 NSC273033 NSC273034 Neosar Occupation, cyclophosphamide exposure Procytox RCRA waste no. U058 Rcra Waste Number U058 Rcra waste number U058 Revimmune S1217_Selleck SK 20501 SPBio_001071 STK177249 STOCK2S-91217 Semdoxan Sendoxan Senduxan Spectrum2_001146 Spectrum3_000370 Spectrum4_000304 Spectrum5_000795 Spectrum_000858 UNII-6UXW23996M WLN: T6MPOTJ BO BN2G2G Zyklophosphamid Zyklophosphamid [German] bis(2-Chloroethyl)phosphami de cyclic propanolamide bis(2-Chloroethyl)phosphamide cyclic propanolamide ester cyclophosphamide |
| | 4 | | Cytarabine | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 1117 | 147-94-4 | 6253 | (beta-D-Arabinofuranosyl)cytosine (beta-D-arabinofuranosyl)cytosine 1-.beta.-D-arabinofuranosyl-cytosine 1-Arabinofuranosylcytosine 1-beta -D-Arabinofaranosylcytosine 1-beta -D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone 1-beta -D-Arabinofuranosylcytosine 1-beta-D-Arabinofaranosylcytosine 1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone 1-beta-D-Arabinofuranosyl-Cytosine 1-beta-D-Arabinofuranosylcytosine 1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside 1-beta-D-Arabinosyl-Cytosine 1-beta-D-Arabinosylcytosine 147-94-4 1beta -Arabinofuranasylcytosine 1beta -D-Arabinofuranosylcytosine 1beta -D-Arabinosylcytosine 1beta-Arabinofuranasylcytosine 1beta-D-Arabinofuranosylcytosine 1beta-D-Arabinosylcytosine 2(1H)-Pyrimidinone, 4-amino-1- -D-arabinofuranosyl- [CAS] 2(1H)-Pyrimidinone, 4-amino-1- -D-arabinofuranosyl 30399_FLUKA 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech] 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine 4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech] 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one 4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one 69-74-9 (hydrochloride) AC-1075 AC1L1M4F AC1Q52OJ AI3-52329 AR3 Alexan Ara-C Ara-C, Cytosine Arabinoside, Cytosar-U, Cytarabine Ara-Cytidine AraC Arabinocytidine Arabinofuranosylcytosine Arabinosyl Cytosine Arabinosylcytosine Arabitin Aracytidine Aracytin Aracytine Arafcyt BIDD:GT0371 BIDD:PXR0139 BTB15125 Beta-cytosine arabinoside C02961 C1768_SIGMA C2035 C9H13N3O5 CCRIS 913 CHEBI:28680 CHEMBL803 CHX 3311 CID6253 CPD000449317 CYTARABINE (SEE ALSO CYTARABINE HYDROCHLORIDE 69-74-9) Citarabina Citarabina [INN-Spanish] Cytarabin Cytarabina Cytarabine (JP15/USP/INN) Cytarabine [USAN:INN:BAN:JAN] | Cytarabine liposome injection Cytarabinoside Cytarabinum Cytarabinum [INN-Latin] Cytarbel Cytonal Cytosar Cytosar-U Cytosine 1-beta-D-arabinofuranoside Cytosine arabinofuranoside Cytosine arabinose Cytosine arabinoside Cytosine arabinoside (VAN) Cytosine beta-D-arabinofuranoside Cytosine beta-D-arabinofuranoside hydrochloride Cytosine beta-D-arabinoside Cytosine, beta -D-arabinoside Cytosine, beta-D-arabinoside Cytosine-1-beta-D-arabinofuranoside Cytosine-1-beta-D-arabinofuranoside hydrochloride Cytosine-beta -D-arabinofuranoside Cytosine-beta -arabinoside Cytosine-beta-D-arabinofuranoside Cytosine-beta-arabinoside Cytosinearabinoside D00168 DB00987 DepoCyte Depocyt Depocyt (TN) Depocyt (liposomal) Depocyte EINECS 205-705-9 Erpalfa FT-0082880 HMS2051K19 HMS2090A18 HSDB 3049 Intrathecal (injected into the spinal fluid) DepoCyt Intrathecal cytarabine (also known as ara-C) Iretin LS-860 Lopac0_000316 MLS000758310 MLS001066340 MolPort-001-792-509 NCGC00093356-03 NCGC00093356-04 NCGC00093356-05 NCI-C04728 NSC 287459 NSC287459 S1648_Selleck SAM001247012 SMR000449317 SR-01000075773-3 Spongocytidine TL8001048 Tarabine U 19920A U-19,920 U-19920 UNII-04079A1RDZ Udicil ZINC03795098 beta -D-arabinosylcytosine beta -arabinosylcytosine beta -cytosine arabinoside beta-Ara C beta-Ara c beta-Arabinosylcytosine beta-Cytosine arabinoside beta-D-Arabinosylcytosine cytarabine cytarabine liposome injection cytosine-β-D-arabinofuranoside |
| | 5 | | Asparaginase | approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 229 | 9015-68-3 | | | Elspar L-asparagine amidohydrolase Putative L-asparaginase precursor |
| | 6 | | Prednisolone | approved, vet_approved | Phase 4, Phase 3, Phase 2, Phase 1 | 1193 | 50-24-8 | 5755 | (11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione .DELTA.1-Cortisol .DELTA.1-Dehydrocortisol .DELTA.1-Dehydrohydrocortisone .DELTA.1-Hydrocortisone .delta.-Cortef .delta.-Stab 1,2-Dehydrohydrocortisone 1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione 1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol 1-Dehydrocortisol 1-Dehydrohydrocortisone 3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene 46656_FLUKA 46656_RIEDEL 50-24-8 58201-11-9 8056-11-9 AC-1773 AC1L1L2E Ak-Pred Ak-Tate Alphadrol Articulose-50 BPBio1_000164 BRD-K98039984-001-03-0 BRN 1354103 BSPBio_000148 Bio-0666 Bubbli-Pred C07369 CCRIS 980 CHEBI:8378 CHEMBL131 CID5755 CO-Hydeltra CPD000718761 Co-Hydeltra Codelcortone Cordrol Cortalone Cotogesic Cotolone D00472 D011239 DB00860 Decaprednil Decortin H Delcortol Delta F Delta(1)-dehydrohydrocortisone Delta-Cortef Delta-Cortef (TN) Delta-Ef-Cortelan Delta-Stab Delta-stab Deltacortenol Deltacortril Deltacortril Enteric Deltahydrocortisone Deltasolone Deltisilone Depo-Medrol Derpo PD Derpo Pd Dexa-Cortidelt Hostacortin H Dexa-Cortidelt hostacortin H Di Adreson F Di-Adreson F Di-Adreson-F Di-adreson F DiAdresonF Dicortol Donisolone Dydeltrone EINECS 200-021-7 Eazolin D Econopred Econopred Plus Erbacort Erbasona Estilsona Fernisolone Fernisolone P Fernisolone-P Flamasone HMS1568H10 HMS2090J05 HSDB 3385 Hostacortin H Hydeltra Hydeltra-Tba Hydeltrasol Hydeltrone Hydrodeltalone Hydrodeltisone Hydroretrocortin Hydroretrocortine I-Pred Inflamase Forte Inflamase Mild K 1557 Key-Pred Klismacort LMST02030179 LS-7669 Lentosone Lite Pred M-Predrol | MLS001304083 MLS002154250 MLS002207037 Medrol Medrol Acetate Metacortandralone Methylprednisolone Acetate Meti-Derm Meticortelone Metreton MolPort-002-507-147 NCGC00179649-01 NSC 9120 NSC9120 NSC9900 Neo-Delta-Cortef Nisolone Nor-Pred T.B.A. Ocu-Pred Ocu-Pred Forte Ophtho-Tate Orapred P0152_SIGMA P0637 P6004_SIGMA PRDL PRED-G Panafcortelone Paracortol Paracotol Pediapred Poly-Pred Precortalon Precortancyl Precortilon Precortisyl Pred Forte Pred Mild Predair Predair A Predair Forte Predalone 50 Predalone T.B.A. Predate Predate Tba Predate-50 Predcor-25 Predcor-50 Predcor-Tba Predisolone Sodium Phosphate Predne-Dome Prednelan Predni-Dome Prednicen Predniliderm Predniretard Prednis Prednisolona Prednisolona [INN-Spanish] Prednisolone (JP15/USP/INN) Prednisolone (anhydrous) Prednisolone Acetate Prednisolone Sodium Phosphate Prednisolone Tebutate Prednisolone [INN:BAN:JAN] Prednisolonum Prednisolonum [INN-Latin] Predonin Predonine Prelone Prenolone Prestwick0_000274 Prestwick1_000274 Prestwick2_000274 Prestwick3_000274 Prestwick_404 Rolisone S1737_Selleck SAM002264639 SMR000718761 SPBio_002367 Scherisolon Solone Steran Sterane Sterolone Supercortisol UNII-9PHQ9Y1OLM Ulacort Ultra Pred Ultracorten H Ultracortene H Ultracortene-H Ultracortene-Hydrogen Ultracortene-hydrogen ZINC03833821 component of Ataraxoid component of K-Predne-Dome delta(1)-Cortisol delta(1)-Dehydrocortisol delta(1)-Dehydrohydrocortisone delta(1)-Hydrocortisone delta(sup 1)-Cortisol delta(sup 1)-Dehydrocortisol delta(sup 1)-Dehydrohydrocortisone delta(sup 1)-Hydrocortisone delta-dehydrocortisol delta-dehydrohydrocortisone delta-hydrocortisone prednisolone | |
| | 7 | | Amoxicillin | approved, vet_approved | Phase 4, Phase 3, Phase 2 | 465 | 26787-78-0 | 33613, 2171 | (-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid (2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 26787-78-0 33911-69-2 34642-77-8 (mono-hydrochloride salt) 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D- (8CI) 6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid 6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin 6-(a-Amino-4-hydroxyphenylacetamido)penicillanic acid 6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid 6-(p-hydroxy-α-aminophenylacetamido)penicillanic acid 6-[[Amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9CI 61336-70-7 (TRIHYDRATE) 6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl 6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid 71447-36-4 81030-75-3 AC-12263 AC1L1PY2 AMC AMOXICILLIN CRYSTALLINE AMOXICILLIN PEDIATRIC AMPC AUGMENTIN '125' AUGMENTIN '200' AUGMENTIN '250' AUGMENTIN '400' AUGMENTIN '500' AUGMENTIN '875' AUGMENTIN ES-600 AX Actimoxi Almodan Ambap26787-78-0 Amix Amoclen Amolin Amopen Amopenixin Amoram Amox Amox 250 Cap 250mg Amox 500 Cap 500mg Amox S 125 Sus 125mg/5ml Amox S 250 Sus 250mg/5ml Amoxi Amoxi-Mast Amoxi-mast Amoxibiotic Amoxicaps Amoxicilina Amoxicilina [INN-Spanish] Amoxicillin (INN) Amoxicillin (TN) Amoxicillin (anhydrous) Amoxicillin (inn) Amoxicillin Trihydrate Amoxicillin and clavulanate potassium Amoxicillin anhydrous Amoxicillin pediatric Amoxicillin trihydrate Amoxicillin(usan) Amoxicilline Amoxicilline [INN-French] Amoxicilline [INN] Amoxicilline [inn] Amoxicillinum Amoxicillinum [INN-Latin] Amoxid Amoxiden Amoxil Amoxivet Amoxycillin Amoxycillin Trihydrate Amoxycillin trihydrate Amoxycillin, BAN Amoxymed Amrit Anemolin Apo-Amoxi Apo-Amoxi Cap 250mg Apo-Amoxi Cap 500mg Apo-Amoxi Pwr for Susp 125mg/5ml Apo-Amoxi Pwr for Susp 250mg/5ml Apo-amoxi Apo-amoxi sugar free Aspenil BL-P 1410 BLP 1410 BPBio1_000499 BRD-K55044200-001-03-9 BRL 2333 BRL-2333 BSPBio_000453 | Biomox Bristamox C06827 CHEBI:2676 CHEBI:53712 CHEMBL1082 CID33613 CPD000058707 Cemoxin Clamoxyl Clamoxyl (SKB) D-(-)-alpha-Amino-p-hydroxybenzyl penicillin D-(-)-alpha-Amino-p-hydroxybenzylpenicillin D-(alpha-Amino-p-hydroxybenzyl)penicillin D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid D-Amoxicillin D07452 DB01060 Delacillin DisperMox Dispermox EINECS 248-003-8 Efpenix Flemoxin Galenamox Gen-Amoxicillin 250mg Gen-Amoxicillin 500mg HMS1569G15 HSDB 3204 Hiconcil Histocillin Hydroxyampicillin Ibiamox Imacillin LS-149721 Lamoxy Larotid MLS000028632 MLS002222248 Metafarma capsules Metifarma capsules MolPort-003-981-182 MolPort-005-933-687 Moxacin Moxal Moxatag NCGC00179554-01 NSC 277174 NSC277174 Novamoxin Cap 250mg Novamoxin Cap 500mg Novamoxin Sus 125mg/5ml Novamoxin Sus 250mg/5ml Nu-Amoxi Cap 250mg Nu-Amoxi Cap 500mg Nu-Amoxi Sus 125/5ml Nu-Amoxi Sus 250mg/5ml Ospamox P-Hydroxyampicillin PHL-amoxicillin PMS-amoxicillin Pamoxicillin Piramox Polymox Prestwick0_000357 Prestwick1_000357 Prestwick2_000357 Prestwick3_000357 Prestwick_713 Prevpac Pro Amox Pwr for Oral Susp 125mg/5ml Pro Amox-250 Cap 250mg Pro Amox-500 Cap 500mg Pro-Amox-250 Orl Sus 250mg/5ml R-Hydroxyampicillin Rimoxallin Ro 10-8756 Robamox SAM002264592 SMR000058707 SPBio_002374 Sauracillin Sawamox PM Sumox Tolodina Trimox Unicillin Utimox Vetramox Wymox Zimox alpha-Amino-p-hydroxybenzylpenicillin amoxicillanyl amoxicillin p-Hydroxyampicillin α-amino-p-hydroxybenzylpenicillin | |
| | 8 | | Idarubicin | approved | Phase 4, Phase 3, Phase 2 | 214 | 58957-92-9 | 42890 | (1S,3S)-3-Acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside (1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside (1s,3s)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-|A-l-lyxo-hexopyranoside (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione (7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione 4-DMD 4-Demethoxydaunomycin 4-Demethoxydaunorubicin 4-Desmethoxydaunorubicin 57852-57-0 57852-57-0 (HYDROCHLORIDE) 58957-92-9 AC1L28SA AC1Q6JJ4 BRD-K69650333-001-01-1 C26H27NO9 CCRIS 5083 CHEBI:42068 CHEMBL1117 CID42890 D08062 DB01177 DM5 DMDR EU-0100600 HMS2089D05 I 1656 I06-1097 I1656_SIGMA IDARUBICIN | IMI 30 IMI-30 Idamycin Idamycin PFS Idarubicin (INN) Idarubicin Aglycone Idarubicin HCl PFS Idarubicin Hcl Idarubicin Hcl Pfs Idarubicin Hydrochloride Idarubicin [INN:BAN] Idarubicina Idarubicina [INN-Spanish] Idarubicine Idarubicine [INN-French] Idarubicinum Idarubicinum [INN-Latin] KBioSS_002388 LS-94015 Lopac0_000600 MLS000759470 NCGC00093976-01 NCGC00093976-02 NCGC00093976-03 NCGC00093976-04 NSC-256439 NSC256439 SMR000466355 UNII-ZRP63D75JW Zavedos Zavedos (TN) idarubicin hydrochloride |
| | 9 | | Epirubicin | approved | Phase 4, Phase 3, Phase 2 | 394 | 56420-45-2 | 41867 | (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside (7S,9R)-7-[(2S,4S,5R,6S)-4-Amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione (7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione 10-((3-amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-(8S-cis)-5,12-naphthacenedione 4'-Epi-DXR 4'-Epiadriamycin 4'-Epidoxorubicin 4'-epi-DX 4'-epi-Doxorubicin 4'-epidoxorubicin 4-Epidoxorubicin 56390-09-1 56390-09-1 (hydrochloride) 56420-45-2 57918-25-9 AC1L26NP AC1Q6JIV BRN 1445813 C11230 C27H29NO11 CCRIS 2261 CHEBI:47898 CHEMBL417 CID41867 D07901 DB00445 Ellence Epi-DX Epi-Dx Epiadriamycin Epidoxorubicin Epirubicin | Epirubicin (INN) Epirubicin [INN:BAN] Epirubicina Epirubicina [INN-Spanish] Epirubicina [Spanish] Epirubicine Epirubicine [French] Epirubicine [INN-French] Epirubicinum Epirubicinum [INN-Latin] Epirubicinum [Latin] Farmorubicin (TN) HSDB 6962 IMI 28 LS-187190 LS-93992 MLS000759412 NChemBio.2007.10-comp15 NSC 256942 NSC-256942 NSC256942 Pharmorubicin Pfs Pidorubicin Pidorubicina Pidorubicina [INN-Spanish] Pidorubicine Pidorubicine [INN-French] Pidorubicinum Pidorubicinum [INN-Latin] Ridorubicin SMR000466308 Triferric doxorubicin UNII-3Z8479ZZ5X WP 697 | |
| | 10 | | Daunorubicin | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 273 | 20830-81-3 | 30323 | (+)-Daunomycin (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranoside (7S,9R)-9-Acetyl-7-[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione (8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro--6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione 11006-54-5 11048-29-6 1407-15-4 149541-57-1 20830-81-3 23942-76-9 27576-81-4 28020-80-6 AB00514669 AC1L1JCP AC1Q29OI AI3-52942 Acetyladriamycin Anthracyline Antibiotics From Streptomyces Coeruleorubidus Antibiotics from Streptomyces coeruleorubidus BPBio1_000389 BRD-K43389675-003-02-7 BRN 1445583 BSPBio_000353 C01907 CCRIS 914 CHEBI:41977 CHEMBL178 CID30323 Cerubidin Cerubidine D07776 DAUNORUBICIN HCL DB00694 DM1 Daunamycin Daunarubicinum Dauno-Rubidomycine DaunoXome DaunoXome (TN) Daunoblastin Daunoblastine Daunomycin | Daunomycin Hydrochloride Daunomycin, Hydrochloride Daunorrubicina Daunorubicin Daunorubicin (INN) Daunorubicin (liposomal) Daunorubicin Hcl Daunorubicin Hydrochloride Daunorubicin [INN:BAN] Daunorubicin, Hydrochloride Daunorubicina Daunorubicine Daunorubicinum Daunorubicinum [INN-Latin] Daunoxome EINECS 244-069-7 FI 6339 FI6339 HMS2089H04 HMS2091K06 HSDB 5095 LMPK13050002 LS-187381 LS-997 Leukaemomycin C MolPort-002-533-961 NCGC00024246-05 NCGC00024246-06 NCGC00025173-01 NCI-C04693 NChemBio.2007.10-comp14 NSC 83142 NSC-82151 Ondena Prestwick3_000487 RCRA waste no. U059 RP 13057 Rcra Waste No. U059 Rp 13057 Hydrochloride Rubidomycin Rubidomycin Hydrochloride Rubomycin Rubomycin C Tocris-1467 UNII-ZS7284E0ZP VS-103 daunorubicin nchembio723-comp2 |
| | 11 | | Hydrocortisone | approved, vet_approved | Phase 4, Phase 3, Phase 2, Phase 1 | 667 | 50-23-7 | 5754, 657311 | (11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione (11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione 11-Hydrocortisone 11-beta-Hydrocortisone 11-beta-Hydroxycortisone 11a-Hydroxycorticosterone 11alpha-Hydroxycorticosterone 11b,17,21-Trihydroxyprogesterone 11b-Hydrocortisone 11b-Hydroxycortisone 11beta,17,21-Trihydroxyprogesterone 11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione 11beta-Hydrocortisone 11beta-Hydroxycortisone 11beta-hydrocortisone 11β-hydrocortisone 17-Hydroxycorticosterone 17a-Hydroxycorticosterone 17alpha-Hydroxycorticosterone 2v95 4-Pregnen-11beta,17alpha,21-triol-3,20-dione 4-Pregnene-11alpha,21-triol 3,20-dione 4-Pregnene-11b,17a,21-triol-3,20-dione 50-23-7 8056-08-4 80562-38-5 8063-42-1 AC-12902 AC1L1L2B ACETASOL HC ACETIC ACID W/ HYDROCORTISONE AI3-25006 AKOS001582651 Acticort Acticort (TN) Aeroseb HC Aeroseb-HC Ala-Cort Ala-Scalp Alacort Algicirtis Alphaderm Amberin Anflam Anti-inflammatory hormone Anucort Anucort-HC Anusol HC Anusol HC (TN) Aquacort Aquanil HC B48448A1-24BA-47CA-8D9E-43E5BC949386 BPBio1_000544 BRD-K93568044-001-03-1 BSPBio_000494 Balneol-hc Barseb HC Basan-Corti Beta-hc Bio-0648 C00735 C21H30O5 CCRIS 5854 CHEBI:17650 CHEMBL389621 CID5754 COR-OTICIN CPD000653523 CaldeCORT Spray Cetacort Chronocort Clear aid Cleiton Cobadex Colocort Colocort (TN) Compound F Compound F (kendall) Cor-Tar-Quin Corhydron Cort-Dome Cort-Quin Cortanal Cortef Cortef (TN) Cortenema Cortesal Corticreme Cortifair Cortifan Cortifoam Cortiment Cortisol Cortisol alcohol Cortisol, Hydrocortisone Cortisolonum Cortisporin Cortisporin Otico Cortispray Cortizol Cortolotion Cortonema Cortoxide Cortril Cremesone Cremicort-H Cutisol Cyclodextrin-encapsulated hydrocortisone D00088 DB00741 DB07886 Delacort Derm-Aid Dermacort Dermaspray Dermil Dermocortal Dermolate Dihydrocostisone Dioderm Dome-cort Domolene-HC Drotic DuoCort EINECS 200-020-1 EU-0100594 Ef corlin Efcorbin Efcortelan Efcortelin Eldecort Eldercort Epicort Epicortisol Epiderm H Esiderm H Evacort Ficortril Fiocortril Flexicort Foille Insetti Genacort Genacort (lotion) Glycort Gyno-Cortisone H 4001 H-Cort H0135_SIGMA H0396_SIGMA H0888_SIGMA H3160_SIGMA H4001_SIGMA H6909_SIGMA HC HC #1 | HC #4 HC (HYDROCORTISONE) HMS1569I16 HMS2090M04 HSDB 3339 HYDROCORTISONE AND ACETIC ACID HYDROCORTISONE IN ABSORBASE Heb Cort Heb-Cort Hi-cor Hidalone Hidro-Colisona Hidrocortisona Hidrocortisona [INN-Spanish] Hycort Hycortol Hycortole Hydracort Hydrasson Hydro-Adreson Hydro-Colisona Hydro-RX Hydro-colisona Hydrocort Hydrocortal Hydrocorticosterone Hydrocortisone Hydrocortisone (JP15/USP/INN) Hydrocortisone Acetate Hydrocortisone Base Hydrocortisone Butyrate Hydrocortisone Sodium Phosphate Hydrocortisone Valerate Hydrocortisone [INN:BAN:JAN] Hydrocortisone alcohol Hydrocortisone base Hydrocortisone free alcohol Hydrocortisone solution Hydrocortisone-Water Soluble Hydrocortisonum Hydrocortisonum [INN-Latin] Hydrocortistab Hydrocortisyl Hydrocortone Hydroskin Hydroxycortisone Hysone Hytisone Hytone Hytone (TN) Hytone lotion Idrocortisone Idrocortisone [DCIT] Incortin-H Incortin-hydrogen Kendall'S compound F Kendall's compound F Komed HC Kyypakkaus LMST02030001 LS-7439 Lacticare HC Lacticare-HC Lactisona Lopac0_000594 Lubricort MLS000069609 MLS001148103 MLS002207135 MLS002222189 Maintasone Medicort Meusicort Mildison Milliderm MolPort-001-794-637 NCGC00022848-06 NCGC00022848-07 NCGC00022848-09 NCGC00022848-12 NCI60_000118 NSC 10483 NSC-10483 NSC10483 Neo-Cort-Dome Neo-Cortef Neosporin-H Ear Nogenic HC Nutracort Nystaform-HC ORLEX HC Optef Otalgine Otic-Neo-Cort-Dome Otobiotic Otocort Otosone-F Pediotic Suspension Penecort Permicort Polcort H Preparation H Hydrocortisone Cream Prepcort Prestwick0_000447 Prestwick1_000447 Prestwick2_000447 Prestwick3_000447 Prestwick_265 Prevex HC Proctocort Proctofoam Proctozone HC Protocort Racet Rectasol-HC Rectoid Reichstein'S substance M Reichstein's substance M Remederm HC S1696_Selleck SAM002264617 SMP1_000156 SMR000059022 SMR000653523 SPBio_002433 Sanatison Scalp-Cort Scalpicin Capilar Schericur Scheroson F Sigmacort Signef Stie-cort Stiefcorcil Synacort Systral Hydrocort Tarcortin Texacort Texacort lotion 25 Timocort Topicort Transderma H Traumaide UNII-WI4X0X7BPJ UPCMLD-DP133 UPCMLD-DP133:001 Uniderm Vioform-Hydrocortisone VoSol HC Vytone Zenoxone [3H]cortisol component of Lubricort component of Neo-Cort-Dome component of Otalgine hydrocortisone | |
| | 12 | | Etoposide | approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 1269 | 33419-42-0 | 36462 | (-)-Etoposide 121471-01-0 136598-18-0 201594-04-9 33419-42-0 35317-32-9 4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside) 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside) 4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside 4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin 4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside 4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside 51854-34-3 76576-58-4 9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one AB00438905 AC1L1FN8 AC1L1VT3 AC1L6246 AC1NR4OG AC1O4WGG AC1O7M1N AC1Q47JJ Ambap33419-42-0 BPBio1_000673 BRD-K37798499-001-02-5 BSPBio_000611 Bio1_000489 Bio1_000978 Bio1_001467 C01576 CCRIS 2392 CHEBI:4911 CHEBI:588795 CHEMBL44657 CID11758093 CID284997 CID3310 CID36462 CID5284558 CID6419930 CID6610299 CPD000112002 D00125 DB00773 DEMETHY-EPIPODOPHYLLOTOXIN,ETHYLIDENE GLUCOSIDE, Demethyl Epipodophyllotoxin Ethylidine Glucoside Demethyl-epiodophyllotoxin ethylidene glucoside Demethylepipodophyllotoxin-beta-D-ethylideneglucoside E0675 E1383_SIGMA EINECS 251-509-1 EPE EPEG ETOP Epipodophyllotoxin Epipodophyllotoxin VP-16213 Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI) Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside) Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside) Eposide Eposin | Eposin, Vepesid, VP-16, Toposar, Etoposide Etopol Etopophos Etopophos (phosphate salt) Etoposid Etoposide Etoposide (JP15/USP/INN) Etoposide (VP16) Etoposide [USAN:INN:BAN:JAN] Etoposido Etoposido [INN-Spanish] Etoposidum Etoposidum [INN-Latin] Etosid HMS1569O13 HMS2052N05 HMS2089F14 HSDB 6517 I06-0248 KBioSS_002410 LS-1214 Lastet MLS000049957 MLS001074951 MLS001424283 MLS002153463 MLS002207239 MLS002222184 MolPort-003-983-431 MolPort-004-905-001 MolPort-004-955-161 NCGC00025056-02 NChemBio.2007.10-comp19 NK 171 NSC 141540 NSC-141540 NSC141540 Prestwick0_000396 Prestwick1_000396 Prestwick2_000396 Prestwick3_000396 Prestwick_211 S1225_Selleck SAM001246880 SMR000112002 SPBio_002532 ST056353 Toposar UNII-6PLQ3CP4P3 VP 16 VP 16 (pharmaceutical) VP 16-213 VP 16213 VP-16 VP-16-213 VePESID (TN) VePesid Vepesid Vepesid J Vepeside ZINC03830818 ZINC03938684 Zuyeyidal etoposide nchembio.573-comp8 nchembio873-comp2 trans-Etoposide |
| | 13 | | Mechlorethamine | approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 397 | 51-75-2 | 4033 | .Beta.,.beta.'-Dichlorodiethyl-N-methylamine 1, 5-Dichloro-3-methyl-3-azapentane hydrochloride 126-85-2 (N-oxide) 2,2'-Dichloro-N-me 2,2'-Dichloro-N-methyldiethylamine 2,2'-Dichlorodiethyl-methylamine 2,2'-dichloro-N-methyldiethylamine 2-Chloro-N-(2-chloroethyl)-N-methylethanamine 302-70-5 (N-oxide, hydrochloride) 51-75-2 55-86-7 (HYDROCHLORIDE) AC1L1H9H Antimit BRN 0605323 BSPBio_001947 Bis(2-chloroethyl)methylamine Bis(beta-chloroethyl) methylamine Bis(beta-chloroethyl)methylamine C07115 C5H11Cl2N CCRIS 447 CHEBI:28925 CHEMBL427 CID4033 Carolysine Caryolysin Caryolysine Chloramine (the nitrogen mustard) Chlorethazine Chlormethine Chlormethine (INN) Chlormethine [INN:BAN] Chlormethinum [INN-Latin] Cloramin Clormetina Clormetina [INN-Spanish] D07671 DB00888 Di(2-chloroethyl)methylamine Dichlor amine Dichloren DivK1c_000759 EINECS 200-120-5 ENT-25294 Embechine Embichin HMS1920J15 HMS2091B04 HMS502F21 HN-2 HN2 HSDB 5083 I14-8708 IBS-L0033631 IDI1_000759 KBio1_000759 KBio2_001369 KBio2_003937 KBio2_006505 KBio3_001447 | KBioGR_001448 KBioSS_001369 LS-7559 MBA Me chloroethamine Mebichloramine Mechlorethamine Mechlorethanamine Mechloroethamine Mecloretamina Mecloretamina [Italian] Methylbis(2-chloroethyl)amine Methylbis(beta-chloroethyl)amine Methyldi(2-chloroethyl)amine Mitoxine (*Hydrochloride*) MolPort-001-785-592 Mustargen Mustine Mustine note Mutagen N,N-Bis(2-chloroethyl)-N-methylamine N,N-Bis(2-chloroethyl)methylamine N,N-Di(chloroethyl)methylamine N-Lost N-Methyl lost N-Methyl-2,2'-dichlorodiethylamine N-Methyl-bis(2-chloroethyl)amine N-Methyl-bis(beta-chloroethyl)amine N-Methyl-bis-chloraethylamin N-Methyl-bis-chloraethylamin [German] N-Methyl-lost N-Methyl-lost [German] N-methyl-bis(2-chloroethyl)amine NCGC00091835-02 NCGC00091835-03 NCGC00091835-04 NCGC00091835-05 NCI60_041682 NINDS_000759 NSC762 Nitol (*Hydrochloride*) Nitrogen mustard Nitrogen mustard (HN-2) Nitrogranulogen SPBio_000496 SPECTRUM1500375 Spectrum2_000448 Spectrum3_000484 Spectrum4_000924 Spectrum5_001702 Spectrum_000889 Stickstofflost (*Hydrochloride*) Stickstofflost (ebewe) T 1024 T-1024 TL 146 UNII-50D9XSG0VR beta,Beta'-dichlorodiethyl-N-methylamine beta,beta'-Dichlorodiethyl-N-methylamine mechlorethamine thyldiethylamine β,β'-dichlorodiethyl-N-methylamine |
| | 14 | | Fludarabine | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 1154 | 21679-14-1, 75607-67-9 | 30751 | (2R,3S,4S,5R)-2-(6-amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol (2R,3S,4S,5R)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol 2-F-ARAA 2-F-ara-A 2-Fluoro Ara-A 2-Fluoro-9-beta-D-arabinofuranosyladenine 2-fluoro ARA-A 21679-14-1 9-beta-D-Arabinofuranosyl-2-fluoroadenine 9-beta-D-arabinofuranosyl-2-fluoro-9H-purin-6-amine 9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-2-fluoro- (9CI) AC1LCW8I AC1Q51CF C10H12FN5O4 CCRIS 3382 CHEMBL1568 CID657237 CPD000058874 D07966 EINECS 244-525-5 F-Ara-A FAMP FT-0082766 FaraA Fludara Fludara, Fludarabine | Fludarabina Fludarabina [Spanish] Fludarabine Fludarabine (INN) Fludarabine 5'-monophosphate Fludarabine [INN] Fludarabine monophosphate Fludarabine phosphate Fludarabinum Fludarabinum [Latin] Fludura Fluradosa Fluradosa (TN) HSDB 6964 I14-4978 LS-15061 MLS000028687 NSC 118218 NSC 118218H NSC-118218 S1491_Selleck SAM002548956 SMR000058874 SQ Fludarabine UNII-1X9VK9O1SC UNII-P2K93U8740 ZINC04216238 | |
| | 15 | | Gemcitabine | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 2018 | 95058-81-4 | 60750 | 103882-84-4 122111-03-9 2',2'-DiF-dC 2',2'-Difluoro-2'-deoxycytidine 2',2'-Difluorodeoxycytidine 2'-Deoxy-.beta.-D-2',2'-difluorocytidine 2'-Deoxy-2',2'-difluorocytidine 4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one 4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one 4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one 4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one 95058-81-4 AB1004842 AC1L1TUQ C07650 CCRIS 8984 CHEBI:175901 CHEMBL888 CID60750 Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine D02368 DB00441 DDFC DFDC DFdC DFdCyd Folfugem GEO Gamcitabine GemLip Gemcel | Gemcin Gemcitabin Gemcitabina Gemcitabina [INN-Spanish] Gemcitabine Gemcitabine (USAN/INN) Gemcitabine HCl Gemcitabine hydrochloride Gemcitabine stereoisomer Gemcitabinum Gemcitabinum [INN-Latin] Gemtro Gemzar Gemzar (hydrochloride) HMS2089P10 HSDB 7567 Inno-D07001 LS-59139 LY 188011 LY-188011 LY188011 NCGC00168784-01 NChemBio.2007.10-comp25 NSC 613327 NSC613327 TL8005979 UNII-B76N6SBZ8R ZINC18279854 Zefei gemcitabine nchembio.573-comp7 nchembio.90-comp2 | |
| | 16 | | Doxorubicin | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 1751 | 23214-92-8 | 31703 | (1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside (8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione 111266-55-8 14-Hydroxydaunomycin 14-Hydroxydaunorubicine 14-hydroxydaunomycin 14-hydroxydaunorubicine 23214-92-8 23257-17-2 24385-08-8 25311-50-6 25316-40-9 25316-40-9 (hydrochloride) 29042-30-6 AC1L1M5T AC1Q29OJ ADM ADR Adriablastin Adriacin (hydrochloride salt) Adriamycin Adriamycin PFS Adriamycin PFS (hydrochloride salt) Adriamycin RDF Adriamycin RDF (hydrochloride salt) Adriamycin Semiquinone Adriamycin semiquinone Adriblas tina Adriblastin Adriblastina Adriblastina (TN) Adriblastina (hydrochloride salt) Aerosolized Doxorubicin BPBio1_000502 BRD-K92093830-003-04-3 BSPBio_000456 BSPBio_001031 C01661 C27H29NO11 CCRIS 739 CHEBI:28748 CHEMBL179 CID31703 Caelyx Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74 Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120 D03899 DB00997 DM2 DOX-SL Doxil Doxo Doxorubicin Doxorubicin (USAN/INN) Doxorubicin HCl | Doxorubicin Hydrochloride Doxorubicin [USAN:INN:BAN] Doxorubicin citrate Doxorubicin hydrochloride (hydrochloride salt) Doxorubicin-P4/D10 Doxorubicin-P4/D10 conjugate Doxorubicin-hLL1 Doxorubicin-hLL1 conjugate Doxorubicina Doxorubicina [INN-Spanish] Doxorubicine Doxorubicine [INN-French] Doxorubicinum Doxorubicinum [INN-Latin] EINECS 245-495-6 FI 106 Farmablastina (hydrochloride salt) HMS2089H06 HSDB 3070 Hydroxydaunomycin hydrochlor ide (hydrochloride salt) Hydroxydaunomycin hydrochloride (hydrochloride salt) Hydroxydaunorubicin Hydroxydaunorubicin hydrochloride (hydrochloride salt) JT9100000 LMPK13050001 LS-1029 LS-165655 MLS000759533 Myocet NCI-C01514 NChemBio.2007.10-comp13 NDC 38242-874 NIOSH/JT9100000 NSC 123127 Prestwick0_000438 Prestwick1_000438 Prestwick2_000438 Prestwick3_000438 Probes1_000151 Probes2_000129 RDF Rubex Resmycin Rubex Rubex (hydrochloride salt) SMP1_000106 SPBio_002395 TLC D-99 ThermoDox Triferric doxorubicin UNII-80168379AG adiblastine (hydrochloride salt) adr iablatina (hydrochloride salt) adriablastine (hydrochloride salt) adriablatina (hydrochloride salt) adriblatina (hydrochloride salt) doxorubicin nchembio809-comp5 |
| | 17 | | Palonosetron | approved, investigational | Phase 4, Phase 2 | 88 | 135729-61-2, 119904-90-4, 135729-56-5 | 148211 | (3aR)-2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-one (3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one (3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one (S-(R*,R*))-2-(1-Azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(de)isoquinolin-1-one 135729-56-5 135729-61-2 2-(1-Azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(de)isoquinolin-1-one 2-Qhbiqo AC1L3WNN Aloxi CID148211 DB00377 LS-186967 LS-187778 NCGC00166415-01 | NCGC00166415-02 Onicit Palonosetron Palonosetron [INN] Palonosetronum Palonosetrón Palonosétron RS 25233-197 RS 25233-198 RS 25259-197 RS 25259-198 RS-25233-197 RS-25233-198 RS-25259-197 RS-25259-198 UNII-5D06587D6R palonosetron |
| | 18 | | Dexamethasone | approved, investigational, vet_approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 2171 | 50-02-2 | 5743 | (3H)-Dexamethasone .delta.(sup 1)-9-.alpha.-Fluoro-16-.alpha.-methylcortisol .gamma.corten 1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone 1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone 1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone 1-Dehydro-16α-methyl-9α-fluorohydrocortisone 137098-19-2 16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol 16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone 16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone 16-alpha-Methyl-9-alpha-fluoroprednisolone 16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol 16alpha -Methyl-9alpha -fluoroprednisolone 16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol 16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone 16alpha-Methyl-9alpha-fluoroprednisolone 16α-Methyl-9α-fluoro-1-dehydrocortisol 23495-06-9 31375_FLUKA 46165_FLUKA 46165_RIEDEL 50-02-2 8054-59-9 9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione 9-Fluoro-16-methylprednisolone 9-alpha-Fluoro-16-alpha-methylprednisolone 9.alpha.-Fluoro-16.alpha.-methylprednisolone 906422-84-2 9A-FLUORO-16BETA-METHYLPREDNISOLONE 9alpha -Fluoro-16alpha -methylprednisolone 9alpha-Fluoro-16alpha-methylprednisolone 9alpha-fluoro-16alpha-methyl-Prednisolone 9α-Fluoro-16α-methylprednisolone AC-11056 AC1L1L1H AC1Q29DM AI3-50934 Adexone Aeroseb-D Aeroseb-Dex Aeroseb-dex Ak Dex Oph Otic Soln 0.1% Alcon Brand of Dexamethasone Anaflogistico Aphtasolon Aphthasolone Apo-dexamethasone Auxiron Azimycin (veterinary) Azium Azium (Veterinary) Azium (veterinary) BIDD:ER0494 BIDD:PXR0060 BRD-K38775274-001-02-3 BRD-K38775274-001-06-4 BSPBio_000995 Bisu DS Bisu Ds C15643 C22H29FO5 CCRIS 7067 CHEBI:41879 CHEMBL384467 CID5743 CPD-10549 CPD001227192 Calonat Corson Corsone Cortisumman D00292 D003907 D1756_SIGMA D4902_SIGMA D6645_SIGMA D8893_SIGMA D9184_SIGMA DB01234 DEX DEXA DEXONE 0.5 DEXONE 0.75 DEXONE 1.5 DEXONE 4 DXM DXMS Decacort Decacortin Decaderm Decadron Decadron (TN) Decadron Tablets, Elixir Decadron, Dexamethasone Decadron-LA Decadron-La Decagel Decaject Decaject L.A. Decaject-L.A. Decalix Decameth Decasone Decaspray Dectancyl Dekacort Delta1-9alpha-Fluoro-16alpha-methylcortisol Deltafluorene Dergramin Deronil Desadrene Desametasone Desametasone [DCIT] Desametasone [Dcit] Desamethasone Desameton Deseronil Dex-Ide Dex-ide Dexa Dexa Mamallet Dexa mamallet Dexa-Cortidelt Dexa-Cortisyl Dexa-Mamallet Dexa-Scheroson Dexa-Sine Dexa-cortidelt Dexa-cortisyl Dexa-scheroson Dexa-sine Dexacen-4 Dexacidin Dexacort Dexacortal Dexacortin Dexadeltone Dexafarma Dexair Dexalona Dexaltin Dexametasona Dexametasona [INN-Spanish] Dexametasone | Dexameth Dexamethansone Dexamethasone Dexamethasone (JP15/USP/INN) Dexamethasone Acetate Dexamethasone Alcohol Dexamethasone Base Dexamethasone Intensol Dexamethasone Sodium Phosphate Dexamethasone [INN:BAN:JAN] Dexamethasone alcohol Dexamethasone base Dexamethasone intensol Dexamethasone-omega Dexamethasonum Dexamethasonum [INN-Latin] Dexamethazone Dexamonozon Dexapolcort Dexapos Dexaprol Dexason Dexasone Dexasone 0.5mg Dexasone 0.75mg Dexasone 4mg Dexasporin Dexinolon Dexinoral Dexone Dexone 0.5 Dexone 0.75 Dexone 1.5 Dexone 4 Dexonium Dexpak Dextelan Dezone Dinormon Dxms ECR Brand of Dexamethasone EINECS 200-003-9 FT-0080377 Fluormethylprednisolone Fluormone Fluorocort Fortecortin Foy Brand of Dexamethasone Gammacorten HL-dex HMS1792A17 HMS1990A17 HMS2089N13 HSDB 3053 Hexadecadrol Hexadrol Hexadrol Elixir Hexadrol Tablets Hexadrol elixir Hl-Dex Hl-dex I06-1196 ICN Brand of Dexamethasone IontoDex Isopto-Dex Isopto-dex LS-7300 Lokalison F Lokalison f Loverine Luxazone MK 125 MLS001055412 MLS001332507 MLS001332508 Maxidex Maxidex Ont 0.1% Maxidex Sus 0.1% Maxitrol Mediamethasone Merck Brand of Dexamethasone Merz Brand 1 of Dexamethasone Merz Brand 2 of Dexamethasone Methylfluorprednisolone Mexidex Millicorten MolMap_000018 MolPort-003-846-433 Mymethasone NCGC00091019-01 NCGC00091019-02 NCGC00091019-03 NCGC00091019-04 NCGC00091019-05 NCI60_003067 NSC 34521 NSC34521 Naquasone (veterinary) Neomycin and polymyxin b sulfates and dexamethasone Neomycin and polymyxin b sulphates and dexamethasone OTO-104 Ocu-Trol Ocu-trol Oradexon PHL-dexamethasone PMS-dexamethasone Pet Derm III Pet Derm Iii Pet derm III Pet-Derm Iii Pms Dexamethasone Elixir 0.5mg/5ml Policort Posurdex Prednisolon F Prednisolon f Prednisolone F Prednisolone f Prodex S1322_Selleck SAM002548948 SGCUT00126 SK-Dexamethasone SK-dexamethasone SMP1_000092 SMR000857119 SMR001227192 ST50307091 Sandoz dexamethasone Sk-Dexamethasone Spectrum5_002019 Spoloven Sunia Sol D Sunia sol D Superprednol TL8003317 Tobradex Tobramycin and dexamethasone Tresaderm (veterinary) Turbinaire UNII-7S5I7G3JQL Visumetazone WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ G1 ZINC03875332 alpha -Fluoro-16-alpha -methylcortisol delta(Sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol delta1-9alpha-Fluoro-16alpha-methylcortisol dexamethasone nchembio809-comp2 to_000038 |
| | 19 | | Pegaspargase | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 129 | 130167-69-0 | | L-asparagine amidohydrolase | Oncaspar Putative L-asparaginase precursor | |
| | 20 | | Mesna | approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 263 | 3375-50-6 | 598 | 2-Mercaptoethane 2-Mercaptoethanesulfonate 2-Mercaptoethanesulfonic acid 2-mercaptoethanesulfonic acid 2-mercaptoethanesulphonic acid 2-mercaptoethylsulfonate 2-sulfanylethylsulfonate | CoM Coenzima M Coenzym M Coenzyme M HS-CoM reduced CoM reduced coenzyme M β-mercaptoethanesulfonic acid | |
| | 21 | | Mitoxantrone | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 272 | 65271-80-9 | 4212 | 1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE 1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione 1,4-Dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione 1,4-Dihydroxy-5,8-bis(5-hydroxy-3-azapentylamino)anthrachinon 1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthra-9,10-quinone 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione 137635-96-2 2fum 5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxyanthraquinone 65271-80-9 70476-82-3 70476-82-3 (hydrochloride) 70711-41-0 70711-41-0 (acetate) 70945-62-9 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)- (9CI) AB00053716 AC1L1HNY AN-584/42007670 BIDD:PXR0181 BPBio1_000627 BRD-K21680192-300-05-2 BRD-K21680192-300-07-8 BRN 2795126 BSPBio_000569 BSPBio_003160 C11195 C22H28N4O6 CAS-70476-82-3 CCRIS 7604 CHEBI:50729 CHEMBL58 CID4212 D08224 DB01204 DHAD DHAQ DHAQ (*Diacetate salt*) DHAQ HCl Dihydroxyanthraquinone DivK1c_000516 HMS2090D05 IDI1_000516 KBio1_000516 KBio2_002135 KBio2_004703 KBio2_007271 KBio3_002660 KBioGR_001531 KBioSS_002135 LS-20638 Liposome Encapsulated Mitoxantrone (LEM) Lopac-M-6545 Lopac0_000779 MITOXANTRONE, 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)ANTHRA-9,10-QUINONE MITOXANTRONE, Mitoxantrone Hydrochloride, Mitoxantrone dihydrochloride, MITOXANTHRONE HYDROCHLORIDE MIX | MLS002703044 Misostol Misostol (TN) Mitox Mitoxanthrone Mitoxantron Mitoxantrona Mitoxantrona [INN-Spanish] Mitoxantrone Mitoxantrone (INN) Mitoxantrone (free base) Mitoxantrone 2HCl Mitoxantrone HCl Mitoxantrone [INN] Mitoxantrone dihydrochloride Mitoxantrone hydrochloride Mitoxantronum Mitoxantronum [INN-Latin] Mitozantrone Mitozantrone hydrochloride MolPort-003-849-239 NCGC00015693-01 NCGC00015693-02 NCGC00015693-04 NCGC00162251-01 NCI60_002276 NCI60_002535 NChemBio.2007.10-comp17 NINDS_000516 NSC 279836 NSC-279836 NSC-287836 NSC-299195 NSC-301739 NSC-301739D NSC279836 NSC299195 NSC301739 Neuro_000153 Novantron Novantrone Novantrone(R) (mitoxantrone for injection concentrate) Prestwick0_000385 Prestwick1_000385 Prestwick2_000385 Prestwick3_000385 S2485_Selleck SMP2_000179 SMR001549953 SPBio_000756 SPBio_002490 SR-01000076001 SR-01000076001-7 STK631833 Spectrum2_000908 Spectrum3_001590 Spectrum4_000866 Spectrum5_001205 Spectrum_001655 UNII-BZ114NVM5P VU0244399-2 mitoxantrone |
| | 22 | | Teniposide | approved | Phase 4, Phase 3, Phase 2 | 21 | 29767-20-2 | 34698 | 23362-13-2 29767-20-2 299-36-5 31514-29-1 35317-44-3 4'-Demethyl-epipodophyllotoxin-beta-D-thenylidene-glucoside 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-2-thenylidene-beta-D-glucopyranoside) 4'-Demethylepipodophyllotoxin 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) 4'-Demethylepipodophyllotoxin thenylidene glucoside 4'-Demethylepipodophyllotoxin-beta-D-thenylidine glucoside 4'-Dimethyl-9-(4,6-O-2-thenyid)-epipodophyllotoxin 4'-demethylepipodophyllotoxin 9-(4,6-O-(R)-2-thenylidene-beta-D-glucopyranoside) 4-Demethylepipodophyllotoxin-.beta.-D-thenylideneglucoside 55256-09-2 AC-759 AC1L1K9H AC1L1S3X AC1L32H7 AC1L5IF3 AC1L9QDK AC1NR4S8 AC1O8FOE AR-1A6252 AR-1A6526 Ambap29767-20-2 BRD-A35588707-001-02-2 BSPBio_003436 C11153 C32H32O13S CCRIS 2058 CHEMBL278534 CID107642 CID275784 CID34698 CID452548 CID5284623 CID5396 CID6708778 D02698 DB00444 Demethyl Epipodophyllotoxin Thenylidine Glucoside DivK1c_006888 EINECS 249-831-2 Epidophyllotoxin Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) FT-0080118 HMS1922B15 HMS2093O15 HSDB 6546 | I06-2040 KBio1_001832 KBio2_002029 KBio2_004597 KBio2_007165 KBio3_002939 KBioGR_001050 KBioSS_002029 KST-1A3576 KST-1A5976 LS-63999 MLS000766234 MolPort-003-666-525 MolPort-005-940-276 MolPort-006-822-656 NCI60_000540 NSC 122819 NSC 12819 NSC-122819 NSC122819 Neuro_000056 PTG S1787_Selleck SMR000528847 SPBio_001773 SPECTRUM1504094 SpecPlus_000792 Spectrum2_001647 Spectrum3_001898 Spectrum4_000585 Spectrum5_001111 Spectrum_001549 Teniposid Teniposide (USAN/INN) Teniposide [USAN:BAN:INN] Teniposido Teniposido [INN-Spanish] Teniposidum Teniposidum [INN-Latin] Téniposide UNII-957E6438QA VM 26 VM-26 Vee M-26 Veham-Sandoz Vehem Vumon Vumon (TN) Vumon, VM-26, Vehem, NSC 122819, Teniposide teniposide | |
| | 23 | | Fosaprepitant | approved | Phase 4, Phase 2, Phase 1, Early Phase 1 | 163 | 172673-20-0 | 219090 | | | 24 | | Melphalan | approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 729 | 148-82-3 | 4053, 460612 | (2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid (2s)-2-amino-3-(4-[bis(2-chloroethyl)amino]phenyl)propanoic acid 148-82-3 3-(P-(Bis(2-chloroethyl)amino)phenyl)-L-alanine 3-(p-(Bis(2-chloroethyl)amino)phenyl)-L-alanine 3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine 3-P-(Di(2-chloroethyl)amino)-phenyl-L-alanine 3-p-(Di(2-chloroethyl)amino)-phenyl-L-alanine 3025 C.B. 3025 c.b 3223-07-2 4-(Bis(2-chloroethyl)amino)-L-phenylalanine 4-14-00-01689 (Beilstein Handbook Reference) 4-[Bis(2-chloroethyl)amino]-L-phenylalanine 4-[Bis-(2-chloroethyl)amino]-L-phenylalanine AC1LA2OE ALKERAN (TN) AY3360000 Alanine Nitrogen Mustard Alkeran AmbotzHAA1563 At-290 BIDD:GT0044 BRD-K87827419-001-02-8 BRN 2816456 BSPBio_002407 C13H18Cl2N2O2 CB 3025 CB-3025 CCRIS 374 CHEBI:165415 CHEBI:28876 CHEMBL852 CID460612 D00369 DivK1c_000653 EINECS 205-726-3 HMS2090B09 HMS2091B16 HMS502A15 HSDB 3234 IDI1_000653 KBio1_000653 KBio2_000877 KBio2_003445 KBio2_006013 KBio3_001627 KBioGR_001284 KBioSS_000877 L-3-(P-(Bis(2-chloroethyl)amino)phenyl)alanine L-3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine L-3-(para-(Bis(2-chloroethyl)amino)phenyl)alanine L-PAM L-Phenylalanine mustard L-Sarcolysin L-Sarcolysine L-Sarkolysin LS-15868 LS-865 | Levofalan Levofolan Levopholan M2011_SIGMA MELPHALAN (SEE ALSO TRANSGENIC MODEL EVALUATION (MELPHALAN)) MLS001333666 MLS002153368 Melfalan Melfalano Melfalano [INN-Spanish] Melphalan (JP15/USP/INN) Melphalan [USAN:INN:BAN:JAN] Melphalanum Melphalanum [INN-Latin] Mephalan MolPort-003-665-535 NCGC00090757-01 NCGC00090757-02 NCGC00090757-03 NCI-C04853 NINDS_000653 NIOSH/AY3360000 NSC 241286 NSC 8806 NSC-8806 NSC241286 NSC8806 P-Di-(2-chloroethyl)amino-L-phenylalanine P-L-Sarcolysin P-N-Bis(2-chloroethyl)amino-L-phenylalanine Phenylalanine mustard Phenylalanine nitrogen mustard Prestwick_1006 RCRA waste no. U150 Rcra waste number U150 SK-15673 SMP2_000174 SMR000058720 SPBio_000287 SPECTRUM1500382 Sarcolysine Sarkolysin Spectrum2_000074 Spectrum3_000684 Spectrum4_000882 Spectrum5_001601 Spectrum_000397 TL8001065 TRANSGENIC LEP (MELPHALAN) (SEE ALSO MELPHALAN) TRANSGENIC MODEL EVALUATION (MELPHALAN) UNII-Q41OR9510P melphalan p-Bis(beta-chloroethyl)aminophenylalanine p-Di-(2-chloroethyl)amino-L-phenylalanine p-L-Sarcolysin p-L-sarcolysine p-N,N-bis(2-chloroethyl)amino-L-phenylalanine p-N-Bis(2-chloroethyl)amino-L-phenylalanine p-N-Di(chloroethyl)aminophenylalanine p-N-di(chloroethyl)aminophenylala nine phenylalanine nitrogen mu stard |
| | 25 | | Ifosfamide | approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 400 | 3778-73-2 | 3690 | (+-)-Ifosfamid (+-)-Ifosphamide (+-)-Tetrahydro-N,3-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide (D,L)-Ifosfamide (R,S)-Ifosphamide (R,S)-N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide 1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide 1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide 2,3-(N,N(sup 1)-Bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxyd 2,3-N,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd 2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis( 2-chloroethyl)tetrahydro-, 2-oxide 2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide 2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide 2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide (8CI) 2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide 3,} 2-oxazaphosphorine oxide 3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorine oxide 3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorine oxide 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorineoxide 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2- oxide 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide 36341-88-5 3778-73-2 84711-20-6 A 4942 AB00513932 AC-2113 AC1L1GHW ASTA Z 4942 Ambap3778-73-2 Asta Z 4942 BPBio1_000865 BRN 0611835 BSPBio_000785 C07047 CAS-3778-73-2 CCRIS 352 CHEBI:5864 CHEMBL1024 CID3690 Cyfos D00343 D007069 DB01181 EINECS 223-237-3 HMS1570H07 HMS2090M12 HMS2093N07 HSDB 7023 Holoxan Holoxan 1000 I-Phosphamide I06-0494 IFEX (TN) Ifex Ifosfamid Ifosfamida Ifosfamida [INN-Spanish] Ifosfamide (JAN/USP/INN) | Ifosfamide Sterile Ifosfamide [USAN:INN:BAN:JAN] Ifosfamidum Ifosfamidum [INN-Latin] Ifosphamide Ifsofamide Iphosphamid Iphosphamid(e) Iphosphamide Iso Endoxan Iso-Endoxan Isoendoxan Isofosfamide Isophosphamide Isosfamide LS-102 LS-99799 MJF 9325 MJF-9325 MLS002154021 Mitoxana Mitoxana, Ifex, Ifosfamide MolPort-003-666-704 N,3-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide N,N-Bis(beta-chloroethyl)-amino-N',O-propylene-phosphoric acid ester diamide N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid [German] N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylen ephosphoric acid diamide N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid diamide N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide N-(2-Chloroethyl)-N-(3-(2-chloroethyl)-2-oxido-1,3,2-oxazaphosphinan-2-yl)amine NCGC00016639-01 NCGC00179435-01 NCI-C01638 NCI60_000233 NPFAPI-04 NSC 109,724 NSC 109724 NSC-109,724 NSC-109724 NSC109,724 NSC109724 Naxamide Prestwick0_000833 Prestwick1_000833 Prestwick2_000833 Prestwick3_000833 S1302_Selleck SMR001233348 SPBio_002706 STL058690 UNII-UM20QQM95Y WLN: T6NPOTJ AM2G BO B2G Z 4942 Z-4942 Z4942 ifosfamide isosfamide {3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1, | |
| | 26 | | Methotrexate | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 1551 | 1959-05-2, 59-05-2 | 126941 | 4-amino-10-methylfolic acid 4-amino-N(10)-methylpteroylglutamic acid Abitrexate Amethopterin Amethopterine Antifolan Arbitrexate Emtexate Folex HDMTX L-Amethopterin Ledertrexate MTX Metatrexan | Methopterin Methotextrate Methotrate Methotrexat Methotrexate Sodium Methotrexatum Methylaminopterin Methylaminopterinum Metotrexato Mexate Méthotrexate N-Bismethylpteroylglutamic Acid N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid Rheumatrex Trexall | |
| | 27 | | Aprepitant | approved, investigational | Phase 4, Phase 2, Phase 1, Early Phase 1 | 163 | 170729-80-3 | 151165, 6918365 | 170729-80-3 221350-96-5 3-(((2R,3S)-3-(P-Fluorophenyl)-2-(((alphar)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(2)-1,2,4-triazolin-5-one 3-(((2R,3S)-3-(p-Fluorophenyl)-2-(((alphaR)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-Delta(2)-1,2,4-triazolin-5-one 3-(((2R,3S)-3-(p-Fluorophenyl)-2-(((alphaR)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(sup 2)-1,2,4-triazolin-5-one 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one 5-[[(2S,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one 5-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-one AC1L45SL AC1OCFCG Aprepitant Aprepitant (JAN/USAN/INN) Aprepitant [USAN] Aprepitantum Aprépitant CHEBI:323967 CHEBI:499361 CHEMBL135613 CHEMBL1471 CHEMBL249465 CID11214788 CID11318675 | CID151165 CID6918365 CID9936947 CID9936948 D02968 DB00673 Emend Emend (TN) HMS2090N12 I06-1151 L 754030 L-754030 LS-156477 MK 0869 MK 869 MK-0517 MK-0869 MK-869 MK-869, L-754030, Emend, Aprepitant MolPort-006-392-367 NCGC00181785-01 ONO-7436 S1189_Selleck UNII-1NF15YR6UY |
| | 28 | | Granisetron | approved, investigational | Phase 4, Phase 2 | 72 | 109889-09-0 | 3510 | 1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide 1-methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide 109889-09-0 AC1NR4P1 APF530 BIDD:GT0272 BRL-43694 C07023 CHEMBL519643 CID5284566 D04370 | Granisetron (USAN/INN) Granisetron HCl Granisetron base Granisetron hydrochloride Granisetronum [INN-Latin] HMS2089P14 Kytril MolPort-005-943-366 granisetron granisetronum granisetrón granisétron | |
| | 29 | | Oxaliplatin | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 1460 | 61825-94-3 | 5310940, 9887054, 6857599, 9887054, 43805 | CHEMBL1201055 CID9887054 D01790 DACPLAT Diaminocyclohexane Oxalatoplatinum Eloxatin Eloxatin (TN) Elplat Foloxatine L-OHP Oxalatoplatin | Oxalatoplatinum Oxaliplatin (JAN/USAN/INN) Oxaliplatin [Usan:Inn:Ban] Oxaliplatino [Spanish] Oxaliplatinum [Latin] Oxaloplatine [French] Oxaloplatino [Spanish] Transplatin oxaliplatin oxaliplatine oxaliplatino oxaliplatinum | |
| | 30 | | Cisplatin | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 2770 | 15663-27-1 | 84093, 441203, 2767 | (SP-4-1)-diamminedichloridoplatinum (SP-4-1)-diamminedichloroplatinum (SP-4-2)-diamminedichloridoplatinum (SP-4-2)-diamminedichloroplatinum Abiplatin Biocisplatinum Briplatin CACP CDDP CHEBI:35852 CID441203 CPD0-1392 CPDC CPDD Carboquone Cis Pt II Cis-DDP Cis-Diaminedichloroplatinum Cis-Diamminedichloroplatinum Cismaplat Cisplatine Cisplatino Cisplatinum Cisplatyl Citoplationo DB00515 DDP DDPT Diamminedichloroplatinum | EU-0100918 Lederplatin Neoplatin Peyrone's chloride Peyrone's salt Plastin Platamine Platiblastin Platidiam Platinex Platinol Platinol-AQ Platinoxan Platinum Ammine Chloride Platinum Ammonium Chloride Platinum Diamine Dichloride Randa Trans-DDP Trans-Diaminedichloroplatinum Trans-Diamminedichloroplatinum Trans-Dichlorodiammine Platinum Trans-Platinumdiammine Dichloride cis-DDP cis-Diamminedichloroplatinum cis-Dichlorodiammineplatinum(II) cis-[PtCl2(NH3)2] cis-diamminedichloridoplatinum(II) cis-diamminedichloroplatinum(II) nchembio773-comp1 trans-diamminedichloridoplatinum(II) | |
| | 31 | | Tropisetron | approved, investigational | Phase 4 | 22 | 105826-92-4, 89565-68-4 | 5595 | (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl 1H-indole-3-carboxylate AC1LCVDG C13666 CHEBI:188800 CHEMBL56564 CID656665 D02130 HMS2090D16 ICS-205930 Lopac-T-104 | MolPort-006-823-819 NCGC00015984-01 NCGC00161414-01 Navoban Navoban (TN) Novaban PDSP1_000776 PDSP2_000764 TKT Tropisetron (INN) [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 1H-indole-3-carboxylate tropisetron |
| | 32 | | Vindesine | approved | Phase 4, Phase 3, Phase 2 | 48 | 59917-39-4, 53643-48-4 | 40839 | 3-(Aminocarbonyl)-O(4)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine 3-(Aminocarbonyl)-O(sup 4)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine 3-(aminocarbonyl)-O(4)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine 3-Carbamoyl-4-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine 3-carbamoyl-O(4)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine 53643-48-4 AC1L24KY C43H55N5O7 CHEBI:36373 CHEMBL219146 CID40839 D06304 DAVA DB00309 Desacetylvinblastine Amide Sulfate Desacetylvinblastine amide EINECS 258-682-2 Eldesine Eldisine | HMS2090E15 HSDB 6961 LS-162145 Lilly 112531 MolPort-005-933-570 NSC-245467 STOCK1N-75293 UNII-RSA8KO39WH Vindesin Vindesina Vindesina [INN-Spanish] Vindesine (USAN/INN) Vindesine Sulfate Vindesine [USAN:BAN:INN] Vindesine [USAN:INN:BAN] Vindesinum Vindesinum [INN-Latin] methyl (5S,7S,9S)-9-[(2b,3b,4b,5a,12b,19a)-3-carbamoyl-3,4-dihydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidin-15-yl]-5-ethyl-5-hydroxy-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methanoazacycloundecino[5,4-b]indole-9-carboxylate methyl (5S,7S,9S)-9-[(2beta,3beta,4beta,5alpha,12beta,19alpha)-3-carbamoyl-3,4-dihydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidin-15-yl]-5-ethyl-5-hydroxy-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methanoazacycloundecino[5,4-b]indole-9-carboxylate vindesine | |
| | 33 | | Methylprednisolone | approved, vet_approved | Phase 4, Phase 3, Phase 2, Phase 1 | 1193 | 83-43-2 | 6741 | (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one (6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione .DELTA.1-6.alpha.-Methylhydrocortisone 1-Dehydro-6alpha-methylhydrocortisone 1-dehydro-6alpha-Methylhydrocortisone 1-dehydro-6α-methylhydrocortisone 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione 11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 121673-01-6 4-08-00-03498 (Beilstein Handbook Reference) 46436_FLUKA 46436_RIEDEL 570-35-4 6 Methylprednisolone 6-Methylprednisolone 6-alpha-Methylprednisolone 6.alpha.-Methylprednisolone 6923-42-8 6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 6alpha-Methylprednisolone 6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 83-43-2 AC1L1N7A Artisone-Wyeth Artisone-wyeth BPBio1_000174 BRD-K35240538-001-03-1 BRN 2340300 BSPBio_000158 Besonia Bio-0658 CHEBI:6888 CHEMBL650 CID6741 CPD000058330 D00407 D008775 DB00959 Depo-Medrol (acetate) Dopomedrol EINECS 201-476-4 Esametone Firmacort HMS1568H20 HMS2090B13 HSDB 3127 LMST02030178 LS-118498 Lemod M0639_SIGMA M1665 MEPRDL MLS000028541 MLS001148159 MLS002207191 Medesone Medixon Medlone 21 | Medrate Medrol Medrol (TN) Medrol Adt Pak Medrol Dosepak Medrol adt pak Medrol dosepak Medrol, Solu-Medrol, Medrone, Methylprednisolone Medrone Mesopren Metastab Methyleneprednisolone Methylprednisolon Methylprednisolone Methylprednisolone (JP15/USP/INN) Methylprednisolone [USAN:INN:BAN:JAN] Methylprednisolone, 6-alpha Methylprednisolonum Methylprednisolonum [INN-Latin] Metilbetasone Metilprednisolona Metilprednisolona [INN-Spanish] Metilprednisolone Metilprednisolone [DCIT] Metilprednisolone [Dcit] Metipred Metrisone Metrocort Metysolon Moderin MolPort-002-528-554 NCGC00022735-03 NCI60_001657 NSC-19987 NSC19987 Nirypan Noretona Predni N Tablinen Prednol- L Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI) Prestwick0_000279 Prestwick1_000279 Prestwick2_000279 Prestwick3_000279 Prestwick_622 Promacortine Reactenol S1733_Selleck SAM002589984 SMR000058330 SPBio_002377 Sieropresol Solomet Summicort Suprametil U 7532 UNII-X4W7ZR7023 Urbason Urbasone Wyacort ZINC03875560 delta(1)-6alpha-Methylhydrocortisone delta(sup 1)-6-alpha-Methylhydrocortisone methylprednisolone methylprenisolone |
| | 34 | | Vincristine | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 922 | 2068-78-2, 57-22-7 | 5978 | 22-Oxovincaleukoblastin 22-Oxovincaleukoblastine 28379-27-3 57-22-7 AC1L1LJC C07204 C46H56N4O10 CCRIS 5763 CHEBI:28445 CID5978 D08679 DB00541 EINECS 200-318-1 HMS2090E19 HSDB 3199 Indole alkaloid LCR LS-228 Leurocristine Lilly 37231 (1:1 sulfate salt) Liposomal Vincristine Marqibo NCGC00163700-01 NCI-C04864 NCI60_026703 NSC-67574 Onco TCS | Oncovin Oncovin (1:1 sulfate salt) Oncovine Tecnocris Tecnocris (TN) UNII-5J49Q6B70F VCR VIN Vincaleukoblastine, 22-oxo- 22-Oxovincaleukoblastine Vincasar Vincasar (1:1 sulfate salt) Vincasar PFS Vincrex Vincrex (1:1 sulfate salt) Vincristin Vincristina Vincristina [DCIT] Vincristine (INN) Vincristine Sulfate Vincristine Sulfate PFS Vincristine [INN:BAN] Vincristinum Vincristinum [INN-Latin] Vincrstine Vincrystine Vinkristin Z-D-Val-Lys(Z)-OH vincristine | |
| | 35 | | Thioguanine | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 83 | 154-42-7 | 2723601 | 154-42-7 2 Amino 6 Purinethiol 2-Amino 6MP 2-Amino 6mp 2-Amino-1,7-dihydro-6H-purin-6-thion 2-Amino-1,7-dihydro-6H-purin-6-thion [Czech] 2-Amino-1,7-dihydro-6H-purine-6-thione 2-Amino-6-MP 2-Amino-6-mercaptopurine 2-Amino-6-merkaptopurin 2-Amino-6-merkaptopurin [Czech] 2-Amino-6-purinethiol 2-Amino-9H-purine-6-thiol 2-Aminopurin-6-thiol 2-Aminopurin-6-thiol [Czech] 2-Aminopurine-6(1H)-thione 2-Aminopurine-6-thiol 2-Thioguanine 2-amino-1,9-Dihydropurine-6-thione 2-amino-1H-purine-6(7H)-thione 2-amino-3,7-dihydropurine-6-thione 2-aminopurine-6-thiol 5580-03-0 6 Thioguanine 6-Mercapto-2-aminopurine 6-Mercaptoguanine 6-TG 6-Thioguanine 6-Thioguanine (6-TG) 6-Thioguanine, Thioguanine A4660_SIGMA A4882_SIGMA AC-11125 AC1MC379 AI3-26078 AKOS003389499 BSPBio_001994 BW 5071 C07648 C5H7N5S CCRIS 8997 CHEBI:136864 CHEMBL727 CID2723601 D013866 D08603 DB00352 DX4 DivK1c_000428 EINECS 205-827-2 FT-0083572 Glaxo Wellcome Brand of Thioguanine Glaxo Wellcome Brand of Tioguanine GlaxoSmithKline Brand of Thioguanine GlaxoSmithKline Brand of Tioguanine Guanine, thio- (VAN) HMS1921E09 HMS2092M11 HMS501F10 HSDB 2504 I14-1541 IDI1_000428 KBio1_000428 KBio2_000715 KBio2_002476 KBio2_003283 KBio2_005044 | KBio2_005851 KBio2_007612 KBio3_001494 KBio3_002954 KBioGR_001452 KBioGR_002476 KBioSS_000715 KBioSS_002483 LS-888 LT00455187 Lanvis Lanvis (TN) MLS001333131 MLS001333132 MolPort-000-929-106 MolPort-001-813-204 MolPort-003-984-174 NCGC00094792-01 NCGC00094792-02 NCGC00094792-03 NCI60_041643 NCIOpen2_004153 NINDS_000428 NSC 752 NSC-752 NSC752 S1774_Selleck SBB067147 SMP2_000326 SMR000857244 SPBio_000849 SPECTRUM1500573 ST50298831 Spectrum2_000695 Spectrum3_000577 Spectrum4_000926 Spectrum5_001455 Spectrum_000235 T0212 TG THG Tabloid ThG Thioguanin GSK Thioguanin-GSK ThioguaninGSK Thioguanine Thioguanine Hemihydrate Thioguanine Monosodium Salt Thioguanine Tabloid Thioguanine [USAN:BAN] Tioguanin Tioguanina Tioguanina Wellcome Tioguanina [INN-Spanish] Tioguanine Tioguanine (INN) Tioguanine GlaxoSmithKline Brand Tioguaninum Tioguaninum [INN-Latin] UNII-FTK8U1GZNX UNII-WIX31ZPX66 WLN: T56 BNM FYM INJ FUS HZ Wellcome Brand of Thioguanine Wellcome U3B ZINC18085533 cMAP_000061 purine antimetabolite: antimetabolite: inhibits nucleic acid replication thioguanine |
| | 36 | | Clarithromycin | approved | Phase 4, Phase 3, Phase 2 | 289 | 81103-11-9 | 84029 | (14R)-14-Hydroxyclarithromycin 116836-41-0 6-O-Methylerythromycin 6-O-Methylerythromycin a 6-O-methyl erythromycin 81103-11-9 A-56268 AC-6813 AC1L1HJO AC1L36NJ AC1NFSZE AC1NR4MY AC1NSJWH AC1O52DV AC1Q6O1T ANX-015 Abbotic Abbott-56268 Adel Astromen BB_NC-1450 BIDD:GT0200 BSPBio_003453 Biaxin Biaxin (TN) Biaxin HP Biaxin XL Biaxin filmtab Biaxin xl filmtab Bicrolid Bio-0020 C06912 C2220 C30H54O11.C9H19NO2 CCRIS 8833 CHEBI:136451 CHEBI:3732 CHEMBL143 CHEMBL1741 CID10147055 CID10328822 CID11814635 CID11828745 CID11969952 CID4663848 CID489010 CID5284534 CID5311050 CID54688 CID6426662 CID84029 CID9810688 CID9811194 CLA CLARITHROMYCIN CLM & IL-12 CPD000466382 CRL-1605 & Clarithromycin CTY Clacine Clambiotic Claribid Claricide Clarith Clarithromycin & Interleukin-12 Clarithromycin (JP15/USP/INN) Clarithromycin [USAN:INN:BAN:JAN] Clarithromycin extended release Clarithromycin suspension or tablets Clarithromycina Clarithromycine Clarithromycine [INN-French] | Clarithromycinum Clarithromycinum [INN-Latin] Claritromicina Claritromicina [INN-Spanish] Clathromycin Cyllid Cyllind D00276 DRG-0099 DivK1c_006655 HMS1922H09 HMS2051G18 HMS2090O11 HMS2094M05 Helas Heliclar I05-0074 KBio1_001599 KBio2_000509 KBio2_003077 KBio2_005645 KBio3_002673 KBioGR_001218 KBioSS_000509 Klacid Klaciped Klaricid Klaricid H.P Klaricid H.P. Klaricid Pediatric Klaricid XL Klarid Klarin Klax Kofron LMPK04000014 LS-1812 Lactoferrin B & Clarithromycin Lactoferrin H & Clarithromycin MLS000759516 MLS001201751 MLS001424066 Mabicrol Macladin Maclar Mavid MolPort-002-507-425 MolPort-003-845-969 MolPort-005-910-192 MolPort-005-934-146 NCGC00178054-01 NSC643733 Naxy O(6)-methylerythromycin SAM001246748 SDP-015 SMR000466382 SPBio_001855 SPECTRUM1504231 STK801952 SpecPlus_000559 Spectrum2_001668 Spectrum3_001667 Spectrum4_000629 Spectrum5_001729 Spectrum_000089 TE-031 TE031 UNII-H1250JIK0A Veclam Zeclar clarithromycin clarithromycina hydro-2H-pyran-2-yl]oxy}-7-methoxy-3,5,7,9,11,13-hexame |
| | 37 | | rituximab | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 1692 | 174722-31-7 | 10201696 | AntiCD20 IDEC-102 IDEC-C2B8 | Ig gamma-1 chain C region MabThera Mabthera Rituxan rituximab |
| | 38 | | Lenograstim | approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 1220 | 135968-09-1 | | G-CSF (CHO cell derived) Glycosylated recombinant G-CSF Glycosylated recombinant granulocyte colony stimulating factor | Granulocyte colony stimulating factor 3 (CHO cell derived) Granulocyte colony-stimulating factor lenograstim Lenograstim (genetical recombination) Lenograstim rDNA | |
| | 39 | | Prednisone | approved, vet_approved | Phase 4, Phase 3, Phase 2, Phase 1 | 1398 | 53-03-2 | 5865 | (1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione (8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione (8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione .delta. E .delta.(sup1)-Cortisone .delta.-Cortelan .delta.-Cortisone .delta.-Cortone .delta.-E .delta.1-Cortisone .delta.1-Dehydrocortisone .delta.sone 1,2-Dehydrocortisone 1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione 1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione 1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione 1-Cortisone 1-Dehydrocortisone 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione 17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione 53-03-2 68-59-7 81552_FLUKA AC-11112 AC1L1LB2 AC1Q29EZ ACon0_000082 ACon1_000297 AI3-52939 Adasone Ancortone Apo-Prednisone Apo-prednisone BPBio1_000323 BRD-K85883481-001-04-2 BSPBio_000293 Betapar Bicortone Bio-0649 C07370 C21H26O5 CCRIS 2646 CHEBI:8382 CHEMBL635 CID5865 CPD001227202 Cartancyl Colisone Cortan Cortancyl Cortidelt Cotone DB00635 Dacorten Dacortin Decortancyl Decortin Decortisyl Dehydrocortisone Dekortin Delcortin Dellacort Dellacort A Delta Cortelan Delta E Delta E. Delta-Cortelan Delta-Dome Delta-cortelan Delta-cortisone Delta-cortone Delta-dome Deltacortene Deltacortisone Deltacortone Deltasone Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone Deltison Deltisona Deltisone Deltra Di-Adreson Diadreson EINECS 200-160-3 Econosone Encorton Encortone Enkortolon Enkorton Fernisone Fiasone HMS1568O15 HMS2090J13 HSDB 3168 Hostacortin In-Sone Incocortyl | Juvason Kortancyl LMST02030180 LS-1325 Liquid Pred Lisacort Lodotra MEGxm0_000443 MLS001061265 MLS001304073 MLS001335907 MLS001335908 MLS002154191 MLS002207083 Me-Korti Metacortandracin Meticorten Meticorten (Veterinary) Metrevet (Veterinary) MolPort-001-740-041 NCGC00090766-01 NCGC00090766-02 NCGC00090766-03 NCI-C04897 NCI60_000008 NSC 10023 NSC10023 Nisona Nizon Novoprednisone Nurison Orasone Origen Prednisone P1276 P6254_SIGMA PRD Panafcort Panasol Paracort Parmenison Pehacort Precort Predeltin Prednicen-M Prednicorm Prednicort Prednicot Prednidib Prednilonga Prednison Prednisona Prednisona [INN-Spanish] Prednisone Prednisone Intensol Prednisone [INN:BAN] Prednisonum Prednisonum [INN-Latin] Prednitone Prednizon Prednovister Presone Prestwick0_000077 Prestwick1_000077 Prestwick2_000077 Prestwick3_000077 Prestwick_405 Pronison Pronisone Rectodelt Retrocortine S1622_Selleck SAM002264641 SK-Prednisone SMR000718760 SMR001227202 SPBio_002214 Servisone Sone Sterapred Supercortil U 6020 UNII-VB0R961HZT Ultracorten Ultracortene WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ Winpred Wojtab ZINC03875357 Zenadrid Zenadrid (veterinary) Zenadrid [veterinary] delta cortelan delta(sup 1)-Cortisone delta(sup 1)-Dehydrocortisone delta-1-Cortisone delta-1-Dehydrocortisone delta-Cortisone delta-Cortone | |
| | 40 | | Dasatinib | approved, investigational | Phase 4, Phase 2, Phase 3, Phase 1 | 285 | 302962-49-8 | 3062316 | (18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide 1N1 2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide 302962-49-8 AC1MI3ET AC1Q2P0C AmbotzLS-1203 Anhydrous dasatinib BCB03_000715 BMS 354825 BMS dasatinib BMS-354825 BMS-354825, Sprycel, BMS354825, Dasatinib BMS354825 C488369 CHEBI:49375 CHEMBL1421 CID3062316 D03658 DB01254 Dasatinib Dasatinib (USAN) Dasatinib (anh.) Dasatinib [USAN] Dasatinib anhydrous Dasatinib, BMS 354825 Dasatinibum EC-000.2122 | EN002710 FT-0084503 I14-1972 Kinome_3650 LS-186641 LS-187028 LS-187773 MolPort-003-846-143 N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, monohydrate N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide NCGC00181129-01 NSC-732517 NSC732517 S1021_Selleck SPRYCEL (TN) Sprycel Spyrcel UNII-X78UG0A0RN anh. dasatinib dasatinib dasatinib (anhydrous) dasatinibum nchembio.117-comp11 nchembio.162-comp4 nchembio.332-comp1 | |
| | 41 | | Metronidazole | approved | Phase 4, Phase 2 | 486 | 443-48-1 | 4173 | 1-(2-hydroxy-1-ethyl)-2-methyl-5-nitroimidazole 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole 1-(beta-Ethylol)-2-methyl-5-nitro-3-azapyrrole 1-(beta-Hydroxyethyl)-2-methyl-5-nitroimidazole 1-(beta-Oxyethyl)-2-methyl-5-nitroimidazole 1-(β-ethylol)-2-methyl-5-nitro-3-azapyrrole 1-(β-hydroxyethyl)-2-methyl-5-nitroimidazole 1-(β-oxyethyl)-2-methyl-5-nitroimidazole 1-Hydroxyethyl-2-methyl-5-nitroimidazole 2-(2-methyl-5-nitroimidazol-1-yl)ethanol 2-Methyl-5-nitro-1-imidazoleethanol 2-Methyl-5-nitroimidazole-1-ethanol 2-methyl-1-(2-hydroxyethyl)-5-nitroimidazole 2-methyl-3-(2-hydroxyethyl)-4-nitroimidazole 2-methyl-5-nitroimidazole-1-ethanol 443-48-1 46461_FLUKA 46461_RIEDEL 69198-10-3 (mono-hydrochloride) 99616-64-5 AB00052046 AC-10556 AC1L1HKS AC1Q2P2Z AKOS000269646 APMN ARONIS24285 Acromona Anagiardil Apo-Metronidazole Arilin Atrivyl BAS 02983617 BAY-5360 BCBcMAP01_000184 BIDD:GT0107 BPBio1_000004 BRD-K52020312-001-05-2 BRN 0611683 BSPBio_000002 BSPBio_002031 Bayer 5360 Bexon Bio-0694 CAS-443-48-1 CB-01-14 MMX CCRIS 410 CHEBI:39845 CHEBI:6909 CHEMBL137 CID4173 CONT CPD000058175 Caswell No. 579AA Clont D00409 DB00916 Danizol Deflamon Deflamon-wirkstoff DivK1c_000007 EINECS 207-136-1 EPA Pesticide Chemical Code 120401 Efloran Elyzol Entizol Eumin FLAGYL I.V. RTU IN PLASTIC CONTAINER Flagemona Flagesol Flagil Flagyl Flagyl (TN) Flagyl 375 Flagyl Er Flagyl I.V. Flagyl I.V. RTU Flegyl Florazole Fossyol Giatricol Ginefla vir Gineflavir HMS1568A04 HMS1920N19 HMS2051G07 HMS2090B19 HMS2091F14 HMS500A09 HMS547C19 HSDB 3129 I14-0667 IDI1_000007 IDR-90105 KBio1_000007 KBio2_001515 KBio2_004083 KBio2_006651 KBio3_001531 KBioGR_000559 KBioSS_001515 Klion Klont LS-1264 M0924 M1547_SIGMA M3761_FLUKA M3761_SIGMA M9036_SIGMA METRO I.V METRONIDAZOLE USP MLS000028590 MLS000758286 Maybridge1_001999 Meronidal Methronidazole Methyl-5-nitroimidazole-1-ethanol | Metric Metric 21 Metro Cream Metro Gel Metro I.V. Metro I.V. In Plastic Container MetroCream MetroGel MetroGel-Vaginal MetroLotion Metrodzhil Metrogel-vaginal (TN) Metrogyl Metrolag Metrolyl Metromidol Metronidaz Metronidazol Metronidazol [INN-Spanish] Metronidazole (JP15/USP/INN) Metronidazole Benzoate Metronidazole Monohydrochloride Metronidazole Phosphoester Metronidazole [USAN:INN:BAN:JAN] Metronidazole in Plastic Container Metronidazolo Metronidazolo [DCIT] Metronidazolum Metronidazolum [INN-Latin] Metrotop Metrozine Metryl Mexibol Mexibol 'silanes' MolPort-000-141-892 MolPort-002-502-101 Monagyl Monasin NCGC00016446-01 NCGC00016446-02 NCGC00022059-03 NCGC00022059-04 NCGC00022059-05 NCIOpen2_000337 NIDA NINDS_000007 NSC 50364 NSC 69587 NSC-50364 NSC50364 NSC69587 Nalox Nidagel Noritate Noritate (TN) Novonidazol Orvagil Prestwick0_000081 Prestwick1_000081 Prestwick2_000081 Prestwick3_000081 Prestwick_334 Protostat RP 8823 RP-8823 Rathimed Rosased S1907_Selleck SAM001247010 SBB041018 SC 10295 SMP1_000189 SMR000058175 SPBio_000666 SPBio_001941 SPECTRUM1500412 STK177359 Sanatrichom Satric Spectrum2_000883 Spectrum3_000506 Spectrum4_000060 Spectrum5_001289 Spectrum_001035 Takimetol Trichazol Trichex Tricho cordes Tricho-gynaedron Trichocide Trichomol Trichomonacid 'pharmachim' Trichopal Trichopol Tricocet Tricom Tricowas B Trikacide Trikamon Trikojol Trikozol Trimeks Trivazol UNII-140QMO216E Vagilen Vagimid Vandazole Vertisal WLN: T5N CNJ A2Q B1 ENW WLN: T5N CNJA2Q B1 ENW WLN: T6NTJ DQ ANU1- ET5N CNJ A1 BNW Wagitran ZERO/004064 ZINC00113442 Zadstat Zidoval giniflavir metronidazole neo-Tric |
| | 42 | | Esomeprazole | approved, investigational | Phase 4, Phase 3, Phase 1 | 333 | 161796-78-7, 119141-88-7 | 4594, 9579578 | ( -)-Omeprazole (-)-Omeprazole (-)-omeprazole (S)-(-)-Omeprazole (S)-(−)-omeprazole (S)-Omeprazole (S)-omeprazole (s)-omeprazole (−)-omeprazole 119141-88-7 119141-89-8 131959-78-9 172964-80-6 193469-77-1 2-(((3,5-Dimethyl-4-methoxy-2-pyridyl)methyl)sulfinyl)-5-methoxy-1H-benzimidazole 2-({[3,5-dimethyl-4-(methyloxy)pyridin-2-yl]methyl}sulfinyl)-5-(methyloxy)-1H-benzimidazole 326602-80-6 5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole 5-Methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole 5-Methoxy-2[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole 5-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1-methyl-1H-benzimidazole 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole 6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole 6-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole 73590-58-6 AC-401 AC1L1IIJ AGI-010 AKOS005066653 AULCER Antra Antra MUPS Audazol Axagon BIDD:GT0020 BIDD:GT0189 BPBio1_000425 BRD-A55962179-001-04-9 BSPBio_000385 Belmazol Bio-0888 C07324 CAS-73590-58-6 CCRIS 7099 CHEBI:50275 CHEBI:519601 CHEBI:7772 CHEMBL1503 CID4594 CID9568614 CID9579578 CPD000058847 Ceprandal D00455 D07917 DB00338 DB00736 DM-3458 Danlox Demeprazol Desec Dizprazol Dudencer Elgam Emeproton Emilok Epirazole Erbolin Esomeprazol Esomeprazole Esomeprazole (INN) Esomeprazole Sodium Esomeprazole [INN:BAN] Esomeprazolum Esomperazole Esopral Exter Gasec Gastrimut Gastroloc Gibancer H 168-68 H 168/68 H-168/68 H168/68 HMS1528I05 HMS1569D07 HMS2052G17 HMS2090E16 HMS2090F11 HSDB 3575 I06-0705 IDI1_032523 InChI=1/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20 Indurgan Inexium paranova Inexium paranova (TN) Inhibitron Inhipump LS-185188 LS-7629 Lensor Logastric Lomac Losec Losec, Omesec, Prilosec, Zegerid, Omeprazole Lucen MLS000069373 MLS001076112 MLS001424148 Maybridge4_002645 Mepral | Miol Miracid MolPort-003-666-741 MolPort-003-807-515 MolPort-003-849-702 MolPort-005-943-880 Mopral Morecon NCGC00016925-01 NCGC00016925-02 NCGC00021522-03 NCGC00021522-04 NCGC00021522-05 Nexiam Nexium Nexium Control Nexium IV Nilsec Nopramin Nuclosina O0359 O104_SIGMA OMEP OMZ Ocid Olexin Olit Omapren Omebeta Omebeta 20 Omed Omegast Omepradex Omepral Omeprazol Omeprazol [INN-Spanish] Omeprazole (JAN/USP/INN) Omeprazole S-form Omeprazole [USAN:INN:BAN:JAN] Omeprazole delayed-release Omeprazole magnesium Omeprazolum Omeprazolum [INN-Latin] Omeprazon Omeprazone Omeprol Omesek Omez Omezol Omezolan Omid Omisec Omizac Ompanyt Ortanol Osiren Ozoken Paprazol Parizac Pepticum Pepticus Peptilcer Perprazole Prazentol Prazidec Prazolit Prestwick0_000493 Prestwick1_000493 Prestwick2_000493 Prestwick3_000493 Prestwick_808 Prilosec Prilosec (TN) Prilosec OTC Procelac Proclor Prysma Ramezol Regulacid Result S1389_Selleck SAM001246900 SAN-15 SMR000058847 SPBio_002306 STK623746 Sanamidol Secrepina TL8005099 Tedec Ulceral UNII-KG60484QX9 UNII-N3PA6559FT UPCMLD-DP075 UPCMLD-DP075:001 Ulceral Ulcesep Ulcometion Ulcozol Ulcsep Ulsen Ultop Ulzol Victrix ZINC04693574 ZINC04693575 Zefxon Zegerid Zepral Zimor Zoltum esomeprazol esomeprazole esomeprazolum omeprazole Ésoméprazole | |
| | 43 | | Infliximab | approved | Phase 4 | 392 | 170277-31-3 | | Ig gamma-1 chain C region Remicade | |
| | 44 | | Azathioprine | approved | Phase 4 | 177 | 446-86-6 | 2265 | 446-86-6 55774-33-9 (hydrochloride salt) 6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine 6-((1-Methyl-4-nitroimidazol-5-yl)thio)purine 6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine 6-(1'-Methyl-4'-nitro-5'-imidazolyl)mercaptopurine 6-(1-Methyl-4-nitroimidazol-5-yl)thiopurine 6-(1-Methyl-4-nitroimidazol-5-ylthio)purin 6-(1-Methyl-4-nitroimidazol-5-ylthio)purin [Czech] 6-(1-Methyl-p-nitro-5-imidazolyl)-thiopurine 6-(1-Methyl-p-nitro-5-imidazolyl)thiopurine 6-(3-Methyl-5-nitro-3H-imidazol-4-ylsulfanyl)-7H-purine 6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine 6-(Methyl-p-nitro-5-imidazolyl)-thiopurine 6-(Methyl-p-nitro-5-imidazolyl)thiopurine 6-({4-nitro-1-methyl-1H-imidazol-5-yl}sulfanyl)-7H-purine 6-1'-Methyl,4'-nitro,5'-imidazolyl mercaptopurine 6-[(1-Methyl-4-nitroimidazol-5-yl)- thio] purine 6-[(1-Methyl-4-nitroimidazol-5-yl)thio]purine 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purine 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-Purine 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-7H-purine 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purine A 4638 A2593_SIAL A4638_SIAL A4638_SIGMA AB00443544 AB00443544-03 AC-4230 AC1L1DAL AC1Q3Z1F AI-981/34845012 AI3-50290 Azamun Azamun [Czech] Azanin Azasan Azasan (TN) Azasan, Imuran, Azamun, BW-57-322, NSC-39084, Azathioprine Azathioprin Azathioprine (JP15/USP/INN) Azathioprine Sodium Azathioprine [USAN:INN:BAN:JAN] Azathioprine sodium Azathioprinum Azathioprinum [INN-Latin] Azathiopurine Azatioprin Azatioprina Azatioprina [INN-Spanish] Azothioprine B. W. 57-322 BPBio1_000054 BRD-K32821942-001-05-6 BRD-K60324116-001-01-5 BSPBio_000048 BSPBio_001876 BW 57-322 BW 57322 BW-57-322 C06837 C9H7N7O2S CAS-446-86-6 CBDivE_013132 CCRIS 62 CHEBI:2948 CHEMBL1542 CID2265 CPD000427366 Ccucol ChemDiv1_002659 Cytostatics D00238 DB00993 DivK1c_000586 EINECS 207-175-4 EU-0100027 FT-0083532 HMS1568C10 HMS1920E17 | HMS2091K19 HMS501N08 HMS594I19 HSDB 7084 IDI1_000586 Immuran Imuran Imuran (TN) Imuran (tn) Imurek Imurel KBio1_000586 KBio2_000464 KBio2_002427 KBio2_003032 KBio2_004995 KBio2_005600 KBio2_007563 KBio3_001376 KBio3_002906 KBioGR_000646 KBioGR_002427 KBioSS_000464 KBioSS_002433 LS-123 Lopac-A-4638 Lopac0_000027 MLS001049307 Methylnitroimidazolylmercaptopurine MolPort-000-745-914 MolPort-000-764-262 MolPort-003-665-485 Muran NCGC00015060-01 NCGC00015060-02 NCGC00015060-04 NCGC00015060-12 NCGC00090836-01 NCGC00090836-02 NCGC00090836-03 NCGC00090836-04 NCGC00090836-05 NCGC00090836-06 NCGC00094593-01 NCGC00094593-02 NCGC00094593-03 NCI-C03474 NINDS_000586 NSC 39084 NSC-39084 NSC39084 Oprea1_375441 Oprea1_533384 Oprea1_633462 Prestwick0_000094 Prestwick1_000094 Prestwick2_000094 Prestwick3_000094 Prestwick_41 S1721_Selleck SAM002589938 SDCCGMLS-0065415.P001 SMR000427366 SPBio_000255 SPBio_001987 SPECTRUM1500133 STK831906 STOCK1S-20293 STOCK1S-27186 Spectrum2_000068 Spectrum3_000308 Spectrum4_000243 Spectrum5_000848 Spectrum_000064 Thiopurine 6-(1-methyl-4-nitroimidazol-5-yl) UNII-MRK240IY2L WLN: T56 BM DN FN HNJ IS- ET5N CNJ A1 DNW ZINC04258316 [Methyl(nitroimidazolyl)mercaptopurine] azathioprine azatiopr in cMAP_000046 | |
| | 45 | | Lansoprazole | approved, investigational | Phase 4, Phase 2 | 218 | 103577-45-3 | 3883 | 103577-45-3 2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole 2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole 2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)-1H-benzimidazole 2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole 2-[({3-methyl-4-[(2,2,2-trifluoroethyl)oxy]pyridin-2-yl}methyl)sulfinyl]-1H-benzimidazole 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl] methyl] sulfinyl] benzimidazole 2-[[[3-methyl-4-(2,2,2-trifluroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole A 65006 A-65006 AB00052388 ABT-006 AC1L1GX8 AG 1749 AG-1749 Abbot Brand of Lansoprazole Agopton Almirall Brand of Lansoprazole Amarin Aprazol BIDD:GT0006 BPBio1_001194 BRD-A49172652-001-05-7 BRN 4333393 BSPBio_001084 BSPBio_001830 Bamalite Bio-0824 Biuret Biuret Gr Biuret Reagent Biuret Reagent Solution Blason C058687 C16H14F3N3O2S CAS-103577-45-3 CG-4801 CHEBI:6375 CHEMBL480 CID3883 CPD000058469 Compraz D00355 DB00448 Dakar DivK1c_000920 EU-0100709 FT-0082011 HMS1571G06 HMS1922M04 HMS2052F05 HMS2093M07 HMS502N22 HSDB 7204 Hoechst Brand of Lansoprazole Hormona Brand of Lansoprazole I06-0018 IDI1_000920 Ilsatec KBio1_000920 KBio2_002060 KBio2_004628 KBio2_007196 KBio3_001330 KBioGR_001491 KBioSS_002060 Ketian L 8533 L8533_SIGMA LS-33080 Lancid Lanfast Lanproton Lansopep Lansophed Lansoprazol Lansoprazol [INN-Spanish] Lansoprazole Lansoprazole (JAN/USP/INN) Lansoprazole [USAN:BAN:INN] Lansoprazole [Usan:Ban:Inn] Lansoprazolum Lansoprazolum [INN-Latin] Lansox Lanston | Lanz Lanzo Lanzol Lanzol-30 Lanzopral Lanzor Lanzul Lapraz Lasoprol Lederle Brand of Lansoprazole Limpidex Linamarin Lopac-L-8533 Lopac0_000709 MLS-0003247.0001 MLS000069705 MLS000759405 MLS001074170 Mesactol MolPort-003-666-508 MolPort-006-394-760 Monolitum NCGC00015615-01 NCGC00015615-02 NCGC00015615-03 NCGC00015615-06 NCGC00015615-11 NCGC00023826-03 NCGC00023826-04 NCGC00023826-05 NCGC00023826-06 NCGC00023826-07 NINDS_000920 Ogast Ogastro Opiren Prestwick0_001072 Prestwick1_001072 Prestwick2_001072 Prestwick3_001072 PrevOnco Prevacid Prevacid (TN) Prevacid I.V Prevacid I.V. Prevacid Iv Prevacid SoluTab Prevacid Solutab Prevacid, Prevacid NapraPAC, Prevacid SoluTab, Lansoprazole Prevpac Prezal Pro Ulco Promeco Promeco Brand of Lansoprazole Promp Prosogan S1354_Selleck SAM001246544 SMR000058469 SPBio_000488 SPBio_002992 SPECTRUM1503926 STK621169 Salvar Brand of Lansoprazole Spectrum2_000444 Spectrum3_000295 Spectrum4_000856 Spectrum5_001521 Spectrum_001580 Suprecid TAK 390MR TAK-390MR TAK390MR TAP Brand of Lansoprazole TL8000155 Takeda Brand of Lansoprazole Takepron Tecnobio Brand of Lansoprazole UNII-0K5C5T2QPG Ulpax Vinas Brand of Lansoprazole Wyeth Brand of Lansoprazole Zoprol Zoton lansoprazole lansoprazole sulphone lanzoprazole | |
| | 46 | | Doxycycline | approved, investigational, vet_approved | Phase 4 | 243 | 564-25-0 | 54671203 | (2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione (2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione (2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione (2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione (4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide 10597-92-9 17086-28-1 (mono-hydrate) 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS) 24390-14-5 41411-66-9 (6-epimer, mono-hydrochloride) 5-Hydroxy-alpha-6-deoxytetracycline 5-hydroxy-α-6-deoxytetracycline 564-25-0 6-Deoxyoxytetracycline 6-Deoxytetracycline 6-alpha-Deoxy-5-oxytetracycline 6-alpha-deoxy-5-oxytetracycline 69935-17-7 (mono-hydrochloride, di-hydrate) 6alpha-Deoxy-5-oxytetracycline 6alpha-deoxy-5-oxytetracycline 6α-deoxy-5-oxytetracycline 7164-70-7 7264-10-0 94088-85-4 (calcium salt (1:2)) AB08 (*Fosfatex) AC1NQXW7 AC1NS4CW AC1NUYS8 AC1O8PYM Alti-Doxycycline Anhydrous doxycycline Apo-Doxy Atridox Azudoxat BCBcMAP01_000024 BIDD:GT0146 BMY-28689 BPBio1_000951 BSPBio_000863 BSPBio_001936 BU-3839T C06973 CHEBI:50845 CHEMBL1433 CID5281011 CID5353597 CID5463943 CID6713981 CPD001550033 D07876 DB00254 DMSC (*Fosfatex) DOXCYCLINE ANHYDROUS DOXY DOXYCYCLINE CALCIUM DOXYCYCLINE MONOHYDRATE Deoxymykoin DivK1c_000345 Dossiciclina Dossiciclina [DCIT] Doxcycline anhydrous Doxiciclina Doxiciclina [INN-Spanish] Doxiciclina [Italian] Doxitard Doxivetin Doxy-Caps Doxy-Puren Doxy-Tabs Doxycen Doxychel Doxychel (TN) Doxycin Doxycyclin Doxycycline (200mg/day) or Placebo | Doxycycline (INN) Doxycycline (TN) Doxycycline (anhydrous) Doxycycline (internal use) Doxycycline Hyclate Doxycycline Monohydrate Doxycycline anhydrous Doxycycline hyclate Doxycycline-Chinoin Doxycyclinum Doxycyclinum [INN-Latin] Doxysol Doxytec Doxytetracycline EINECS 209-271-1 GS-3065 (*monohydrate) HMS2090E06 HSDB 3071 Hydramycin IDI1_000345 Investin Jenacyclin KBio1_000345 KBio2_001287 KBio2_003855 KBio2_006423 KBio3_001156 KBioGR_001133 KBioSS_001287 LS-187766 LS-93868 Liviatin Lopac0_000405 MolPort-002-507-423 Monodox Monodox (*monohydrate) NCGC00161602-01 NCGC00161602-03 NCGC00161602-04 NCGC00167961-01 NCGC00179395-01 NINDS_000345 NSC633557 Novo-Doxylin Nu-Doxycycline Oracea Prestwick0_000852 Prestwick1_000852 Prestwick2_000852 Prestwick3_000852 Ronaxan SAM002589932 SMP1_000107 SPBio_000246 SPBio_002784 STOCK1N-34341 Spanor Spectrum2_000143 Spectrum3_000408 Spectrum4_000527 Spectrum5_000947 Spectrum_000807 Supracyclin UNII-334895S862 UPCMLD-DP021 UPCMLD-DP021:001 Vibra-tabs Vibramycin Vibramycin (*monohydrate) Vibramycin Novum Vibramycine Vibravenos Vivox (*Hyclate) alpha-6-Deoxy-5-hydroxytetracycline alpha-6-Deoxyoxytetracycline alpha-Doxycycline doxycycline |
| | 47 | | leucovorin | approved, Nutraceutical | Phase 4, Phase 3, Phase 2, Phase 1 | 3235 | 58-05-9 | 54575, 6560146, 143 | (5-formyl-5,6,7,8-tetrahydropteroyl)glutamate (6R,S)-5-Formyltetrahydrofolate 10-Formyl-7,8-dihydrofolate 10-Formyl-7,8-dihydrofolic acid 5-Formyl-5,6,7,8-tetrahydrofolate 5-Formyl-5,6,7,8-tetrahydrofolic acid 5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid 5-Formyltetrahydrofolate 5-Formyltetrahydrofolic acid 5-Formyltetrahydropteroylglutamate 5-Formyltetrahydropteroylglutamic acid 5-formyltetrahydrofolic acid Acide folinique Calcium citrovorum factor Calcium folinate Citrovorum factor Folinate Folinic acid Folinic acid calcium salt | Folinic acid calcium salt USP27 Folinic acid-SF L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid L-Leucovorin L-N-[p-[[(2-Amino-5-formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-Glutamic acid L-leucovorin Leucal Leucovorin calcium Leucovorin folinic acid Leucovorinum Leukovorin Levoleucovorin N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid N5-Formyl-5,6,7,8-tetrahydrofolate N5-Formyl-5,6,7,8-tetrahydrofolic acid N5-Formyl-THF N5-Formyltetrahydrofolate N5-Formyltetrahydrofolic acid Welcovorin Wellcovorin folinate |
| | 48 | | Folic Acid | approved, nutraceutical, vet_approved | Phase 4, Phase 3, Phase 2, Phase 1 | 4392 | 59-30-3 | 6037 | (2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid 01769_FLUKA 2d0k 33609-88-0 36653-55-1 (mono-potassium salt) 59-30-3 6484-89-5 (mono-hydrochloride salt) AC-11682 AC1L1LNX AI3-26387 AKOS000503224 ARONIS014410 Acfol (Spain) Acide folique Acide folique [INN-French] Acido folico Acido folico [INN-Spanish] Acidum folicum Acidum folicum [INN-Latin] Acifolic Antianemia factor Apo-Folic BIDD:ER0563 BIDD:GT0641 BIF0608 BPBio1_000654 BSPBio_000594 BSPBio_002338 C00504 C20H20N6O6 CAS-59-30-3 CCRIS 666 CHEBI:27470 CHEMBL1622 CID6037 CPD000471860 Cytofol D00070 DB00158 DivK1c_000494 Dosfolat B activ EINECS 200-419-0 F0043 F7876_SIAL F7876_SIGMA F8758_SIGMA F8798_SIAL F8890_SIGMA FOL Facid Factor U Folacid Folacin Folaemin Folaemin [Netherlands] Folan Folasic (Australia) Folate Folbal Folcidin Folcidin (VAN) Folcysteine Foldine Foldine [France] Folettes Foliamin Folic Folic acid Folic acid (JP15/USP/INN) Folic acid (TN) Folic acid [BAN:INN:JAN] Folic acid [INN:BAN:JAN] Folic acid dihydrate Folicet Folicet (TN) Folico Folico (Italy) Folina Folina (Italy) Folipac Folsaeure | Folsan Folsaure Folsav Folvite Folvron Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L HMS1921D20 HMS2092N17 HMS501I16 HSDB 2002 IDI1_000494 InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s Incafolic KBio1_000494 KBio2_001861 KBio2_004429 KBio2_006997 KBio3_001558 KBioGR_002222 KBioSS_001861 Kyselina listova Kyselina listova [Czech] LS-2157 Liver Lactobacillus casei factor MLS001304016 MLS001335861 Millafol Mission prenatal Mittafol MolPort-004-285-551 N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid N-Pteroyl-L-glutamic acid N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid NCGC00016265-01 NCGC00142391-01 NINDS_000494 NSC 3073 Nifolin Nifolin [Denmark] Novofolacid Novofolacid [Canada] PGA PGA (VAN) Prestwick3_000627 Prestwick_230 PteGlu Pteroyl-L-glutamate Pteroyl-L-glutamic acid Pteroyl-L-monoglutamate Pteroyl-L-monoglutamic acid Pteroylglutamate Pteroylglutamic acid Pteroylmonoglutamate Pteroylmonoglutamic acid SAM002264616 SDCCGMLS-0066738.P001 SMP2_000137 SMR000471860 SPBio_001357 SPECTRUM1502020 Serum Folate Level Spectrum2_001459 Spectrum3_000749 Spectrum4_001751 Spectrum5_000602 Spectrum_001381 UNII-935E97BOY8 Usaf cb-13 Vitamin B11 Vitamin B9 Vitamin Bc Vitamin Be Vitamin M bmse000299 folic acid nchembio.108-comp10 | |
| | 49 | | Butyric Acid | experimental | Phase 4, Phase 3, Phase 2, Phase 1 | 380 | 107-92-6 | 264 | 1-Butanoate 1-Butanoic acid 1-Butyrate 1-Butyric acid 1-Propanecarboxylate 1-Propanecarboxylic acid 1-propanecarboxylic acid Butanate Butanic acid Butanoate Butanoic acid Buttersaeure Butyrate Butyric acid | Butyricum acidum Ethylacetate Ethylacetic acid Honey robber Kyselina maselna N-Butanoate N-Butanoic acid N-Butyrate N-Butyric acid N-butanoic acid N-butyric acid Propanecarboxylate Propanecarboxylic acid Propylformate Propylformic acid | |
| | 50 | | Doxil | Approved June 1999 | Phase 4, Phase 3, Phase 2, Phase 1 | 1751 | | 31703 | | Evacet LipoDox Pegylated Liposomal Doxorubicin Hydrochloride liposomal doxorubicin |
|
Interventional clinical trials: (show top 50)
(show all 703)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer | Unknown status | NCT00274885 | Phase 4 | | 2 | Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH) | Unknown status | NCT02347878 | Phase 4 | | 3 | German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003) | Unknown status | NCT00198991 | Phase 4 | | 4 | German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | Unknown status | NCT00198978 | Phase 4 | | 5 | An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn's Disease. | Completed | NCT00440817 | Phase 4 | | 6 | German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults | Completed | NCT00199017 | Phase 4 | | 7 | Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-grade Lymphoma in Adults | Completed | NCT00199082 | Phase 4 | | 8 | PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation | Completed | NCT00352703 | Phase 4 | | 9 | AMENO-2: Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors | Completed | NCT00415103 | Phase 4 | | 10 | Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia | Completed | NCT01358253 | Phase 4 | | 11 | Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic Leukemia | Completed | NCT00411541 | Phase 4 | | 12 | Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia | Completed | NCT00199095 | Phase 4 | | 13 | German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (05/93) | Completed | NCT00199069 | Phase 4 | | 14 | German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (06/99) | Completed | NCT00199056 | Phase 4 | | 15 | Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab | Completed | NCT00199004 | Phase 4 | | 16 | LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive | Completed | NCT00526305 | Phase 4 | | 17 | Surgery Alone, Surgery With Cyclophosphamide, Vinblastine, and Prednisolone (CVP), or CVP Alone in Treating Young Patients With Stage IA or Stage IIA Nodular Lymphocyte-Predominant Hodgkin Lymphoma | Recruiting | NCT01088750 | Phase 4 | | 18 | Treatment of Natural Killer/T Cell Lymphoma-I/II | Recruiting | NCT01501136 | Phase 4 | | 19 | Treatment of Natural Killer/T Cell Lymphoma-Ⅲ/Ⅳ | Recruiting | NCT01501149 | Phase 4 | | 20 | Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell Lymphomas | Recruiting | NCT03071822 | Phase 4 | | 21 | A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL) | Recruiting | NCT01804166 | Phase 4 | | 22 | EDOCH Alternating With DHAP for New Diagnosed Younger MCL | Recruiting | NCT02858804 | Phase 4 | | 23 | CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma | Recruiting | NCT01746992 | Phase 4 | | 24 | CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL | Recruiting | NCT02533700 | Phase 4 | | 25 | Thiopurine Induced Pancreatitis in IBD Patients | Recruiting | NCT02281799 | Phase 4 | | 26 | Intraluminal Therapy for Helicobacter Pylori Infection | Recruiting | NCT03124420 | Phase 4 | | 27 | Rituximab (RTX) Therapy in Patients With Active TAO | Recruiting | NCT02378298 | Phase 4 | | 28 | PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 Years | Recruiting | NCT01358201 | Phase 4 | | 29 | Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study | Recruiting | NCT02894645 | Phase 4 | | 30 | Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS | Recruiting | NCT01540812 | Phase 4 | | 31 | The GD-2008 ALL Protocol for Childhood Acute Lymphoblastic Leukemia | Recruiting | NCT00846703 | Phase 4 | | 32 | A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation | Active, not recruiting | NCT02576327 | Phase 4 | | 33 | Treatment of High Risk Adult Acute Lymphoblastic Leukemia | Active, not recruiting | NCT00853008 | Phase 4 | | 34 | 10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection | Not yet recruiting | NCT02959255 | Phase 4 | | 35 | Complete Mesocolon Excision vs Locoregional Lymphadenectomy in Sigmoid Colon Cancer (CMELL) | Not yet recruiting | NCT03083951 | Phase 4 | | 36 | High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection | Not yet recruiting | NCT02553083 | Phase 4 | | 37 | Low-dose Chemotherapy Combine With Tyrosine Kinase Inhibitor to Treat ph+ Acute Lymphoblastic Leukemia Patients | Not yet recruiting | NCT02690922 | Phase 4 | | 38 | Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome | Terminated | NCT01625455 | Phase 4 | | 39 | Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach | Unknown status | NCT00003617 | Phase 3 | | 40 | Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma | Unknown status | NCT00016887 | Phase 3 | | 41 | Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Non-Hodgkin's Lymphoma | Unknown status | NCT00006250 | Phase 3 | | 42 | Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma | Unknown status | NCT00003639 | Phase 3 | | 43 | Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma | Unknown status | NCT00006455 | Phase 3 | | 44 | Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma | Unknown status | NCT00003423 | Phase 3 | | 45 | Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma | Unknown status | NCT00003650 | Phase 3 | | 46 | Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma | Unknown status | NCT00025636 | Phase 3 | | 47 | A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients | Unknown status | NCT01303887 | Phase 3 | | 48 | Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma | Unknown status | NCT00678327 | Phase 3 | | 49 | Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma | Unknown status | NCT00003728 | Phase 3 | | 50 | Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL | Unknown status | NCT00209222 | Phase 3 |
|
